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CHAPTER I 
 
INTRODUCTION 
 
Adenoviruses (Ads) are a large family of non-enveloped, double-stranded DNA 
viruses that are a significant cause of acute respiratory, gastrointestinal, and ocular 
infections in human hosts. Adenoviruses can present more serious illnesses in 
immunocompromised individuals with AIDS or those undergoing chemotherapy or bone 
marrow transplants. Adenovirus has served as an important system for uncovering a wide 
array of cellular and molecular processes including RNA splicing and cell cycle 
regulation. Adenoviruses currently represent a significant proportion of the viral vectors 
used for gene therapy and vector-based vaccine applications due to high titer production, 
wide tropism, ability to infect dividing and non-dividing host cells, high stability in vivo, 
absence of chromosomal integration, and high infection efficiency (118).  
 
Adenovirus-based Vectors 
Adenovirus vectors have been utilized as therapeutic agents in a host of diseases 
including cancer. To address the genetic lesions that lead to cancer, numerous 
adenovirus-vector based gene therapy approaches have been developed with the newest 
being oncolytic therapy or virotherapy. Virotherapy relies on the ability of the virus to 
replicate in and lyse tumor cells. Adenoviruses have a lytic life cycle, but early vectors 
were replication-defective meaning that infection of the target host cell was a terminal 
event. These vectors would have low efficacy in virotherapy where infection of 
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surrounding tumor cells is essential. Conditionally replicating Adenovirus vectors 
(CRAds) with mutations in the E1B gene were created to allow vectors to replicate in p53 
deficient tumors (6). The E1B 55-kDa protein binds and inactivates p53 to block 
apoptosis long enough to allow viral replication. In the absence of the E1B gene in 
CRAds, healthy cells are thought to undergo apoptosis when infected, whereas tumor 
cells would allow replication, lysis, and infection of the surrounding tumor cells. First 
generation CRAds are well tolerated by patients with various cancers in phase I and II 
clinical trials (51, 70). Unfortunately, the efficacy of CRAd virotherapy is limited by the 
variable expression of the attachment receptor on tumor cells (58, 106, 151).  Also, since 
the attachment receptor is abundant on liver cells, particle uptake and sequestration in the 
liver are hepatotoxic and activate the host immune response (94). 
 
Vector Retargeting
 Efficient Adenovirus cell entry involves association with two receptors. Most of 
the 51 different Adenovirus serotypes, including Ad5 used in CRAds, recognize CAR 
(Coxsackievirus and Adenovirus Receptor) for cell attachment and subsequently αv 
integrins for internalization (122). The immune response resulting from vector uptake and 
sequestration in the liver may be circumvented by redirecting the vector away from liver 
cells and towards tumor cells. Therefore, to bypass the liver, the main strategy is to block 
the Ad5 fiber from attaching to liver cells via CAR. To achieve this end three approaches 
have been undertaken: first, development of bispecific retargeting ligands such as 
bispecific fusion antibodies that recognize the adenovirus fiber and tumor cell markers 
(75); second, vectors with genetically modified capsid proteins (e.g. protein IX) which 
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can incorporate biotinylated cellular targeting ligands (14); and third, pseudotyped 
vectors.  
Pseudotyped vectors take advantage of the fact that some adenovirus serotypes 
recognize attachment receptors other than CAR. Subgroup B and D adenoviruses, 
including Ad35 (subgroup B) utilize an alternate attachment receptor, CD46/MCP 
(membrane cofactor protein) (41). CD46 is a member of the family of complement 
regulatory proteins and an attachment receptor for several microbial pathogens as well as 
for a subset of adenovirus serotypes. In humans, CD46 is expressed at low levels in all 
nucleated cells, but it is overexpressed in malignant tumors (38). Ad35 is a rare human 
pathogen that is associated with infections in immunocompromised patients. Ad35 has 
received attention as a potential gene delivery vector since it can overcome pre-existing 
anti-adenovirus immunity, and it can infect non-CAR expressing cells such as 
hematopoietic cells (87, 114). In a transgenic mouse model with CD46 expressed at 
levels similar to humans, an adenovirus vector with the capsid of Ad5 and the fiber of 
Ad35 (Ad35F) preferentially targets tumors overexpressing CD46 and has anti-tumor 
properties (83). 
 
Adenovirus Structure
A detailed structural understanding of adenovirus would complement vector 
design; however, a high resolution structural analysis of intact adenovirus has been 
confounded by the large size and complexity of the virus. Adenoviruses are composed of 
eleven different structural proteins and a double-stranded DNA genome with a total 
molecular mass of 150 MDa. The icosahedral capsid is ~927 Å in diameter, not including 
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the fibers that vary in length from approximately 120 to 315 Å depending on the serotype. 
The mature adenovirus virion has an icosahedral protein capsid that is composed of three 
major capsid proteins (240 hexons, 12 penton bases, and 12 fibers) and four additional 
capsid proteins (proteins IIIa, VI, VIII and IX) (Table 1.1). Its double-stranded DNA 
genome is packaged inside of the capsid together with four core proteins (V, VII, mu, and 
terminal protein) and multiple copies of the Adenovirus protease. Cryoelectron 
microscopy (cryoEM) structures of adenovirus (36, 104), Ad/receptor (22), Ad/antibody 
(134), and the Adenovirus penton base dodecamer (108) complexes combined with 
crystal structures for hexon (103), penton base (36), the fiber knob (13, 32, 132, 147), and 
the fiber shaft (133) have provided a wealth of structural information on Ad, but 
significant gaps remain in our knowledge of the virus capsid structure. The structure and 
capsid locations of proteins that play important roles in the virus life cycle (proteins IIIa 
and VI) and function in capsid integrity (proteins VIII and IX) remain poorly defined. 
 4
 
 
Table 1.1. Capsid proteins of adenovirus serotype 5. 
1Size in mature virion. 
2Trimers of polypeptide II form 240 hexons. 
3Pentamers of polypeptide III form 12 penton bases. 
4Trimers of polypeptide IV form 12 fibers, one extending from each penton base. 
5323 amino acids in Ad35. 
635.4 kDa in Ad35. 
Name Number of 
amino 
acids 
Size 
(kDa)1
Copy 
Number 
Radial 
Capsid 
Location 
Function 
II2 951 107.9 720 exterior Major capsomer. 
 
III3 571 63.3 60 exterior The penton base interacts with 
the internalization receptor: 
αvβ3 or αvβ5 integrins (139). 
 
IIIa 585 63.5 60 exterior/ 
interior 
Viral assembly (9, 25). 
 
 
IV4 5815 61.66 36 exterior The fiber attaches to the host 
cell via the C-terminal knob. 
 
VI 250 22.1 ~ 360 interior The C-terminus is a cofactor for 
the adenovirus protease (71, 
138). 
     Protein VI regulates the nuclear 
import of newly translated 
hexon for viral assembly (141). 
     Protein VI is an endosomal 
penetration protein (140). 
 
VIII 227 7.6 
12.1 
~ 120 interior Capsid stability (65). 
 
 
IX 140 14.4 240 exterior Capsid stability. 
     Viral transcriptional activator 
(98). 
     Protein IX suppresses a cellular 
antiviral response (98, 99). 
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 Protein IIIa 
Protein IIIa participates in viral assembly and maturation as several temperature-
sensitive mutants that affect protein IIIa are defective for assembly (9, 25). Protein IIIa is 
present in 60 copies per virion and is cleaved near the C-terminus by the adenovirus 
protease during virus maturation to form a mature protein of 570 residues with a 
molecular mass of 63.5 kDa (Table 1.1) (61, 123). Early immunoprecipitation studies 
with anti-IIIa antibodies suggested an external location for a least one domain of protein 
IIIa (34). In contrast, argon plasma etching experiments, cross-linking studies, and 
proteolytic processing during maturation pointed to an internal position for protein IIIa 
between the adenovirus capsid and core (34, 82). The first cryoEM difference map at ~25 
Å resolution tentatively assigned one domain of protein IIIa to density observed at the 
facet edge on the exterior of the capsid and a second domain to density on the capsid 
interior (123). 
 
Fiber 
The fiber is a trimer of protein IV, and it extends from each penton base (Table 
1.1). The virus attaches to the host cell via the knob at the C-terminus of the fiber. The 
shaft of the fiber is composed of 15 amino acid consensus repeats that form β-spiral 
motifs (133). The number of repeats varies among serotypes from 5 and a half in Ad35 to 
22 in Ad5. A crystal structure of the Ad12 fiber knob bound to the first Ig-like-domain of 
CAR shows the fiber interacting with CAR via the side of the knob (5). This tangential 
arrangement suggests that the fiber must flex to accommodate such an interaction. Many 
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adenovirus serotypes, including Ad5, contain an insertion in a β-turn in the third repeat 
from the N-terminus (near the penton base) that could be responsible for the bend 
observed by negative stain EM of isolated fibers (101). A cryoEM reconstruction of Ad5 
shows contiguous fiber density from the capsid until a point corresponding to the third 
repeat, after which the density becomes diffuse. Conversely, fibers without an insertion in 
the third repeat like the fiber from Ad37 are more rigid as shown by the fully 
reconstructed Ad37 fiber (23). The presence of the nonconsensus repeat in the fiber shaft 
can be used as a predictor of fiber flexibility. The Ad35 fiber also has the nonconsensus 
repeat, so it is predicted to be flexible.   
 
Protein VI 
Protein VI has at least three roles in the adenovirus life cycle. The first biological 
role of protein VI is that the cleaved C-terminal peptide serves as a cofactor for the 
adenovirus protease (71, 138). Also, protein VI regulates hexon import into the nucleus 
during adenovirus assembly (141). Lastly, protein VI participates in endosomal 
disruption following cell entry (140). Protein VI is present in 369 +/- 34 copies per virion 
(61) and is cleaved near both the N- and C-termini by the adenovirus protease to form a 
mature protein of 22.1 kDa (Table 1.1) (61). 
Protein VI is thought to be located on the inner capsid surface and has been 
reported to bind DNA (102). It crosslinks to protein V, a core protein (34) and is 
degraded with a rate similar to core proteins in Argon plasma etching (82). Direct 
association between protein VI and hexon has been demonstrated (72). In a 25 Å 
resolution difference map, protein VI was assigned to internal density associated with the 
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penton base and peripentonal hexons and was suggested to be a trimer of dimers. A 
genetic analysis of the Ad5 ts147 temperature-sensitive mutant, which has a defect in 
nuclear import of hexon, indicates that hexon residue 776 (which is mutated from G to D 
in ts147) is most likely a key residue in the hexon/protein VI interaction (141). This 
residue is within the cavity of the hexon trimer and is exposed to the interior of the virion. 
At non-permissive temperatures the ts147 mutant accumulates newly synthesized hexon 
trimers in the cytoplasm but the nuclear import of hexon, which is necessary for viral 
assembly in the nucleus, is impaired (57). In order to efficiently shuttle hexon to the 
nucleus, it is possible that protein VI associates with hexons regardless of their positions 
in the assembled virion. Consideration of the capsid protein stoichiometry in the mature 
virion indicates 1 to 2 copies of protein VI per hexon trimer, with ~369 copies of protein 
VI to 240 hexon trimers per virion. A high resolution structure of adenovirus may be 
necessary to determine whether protein VI associates preferentially with peripentonal 
hexons as proposed in the first adenovirus difference map or binds equivalent sites in 
other hexons in the asymmetric unit.  
 
Protein VIII 
The location of protein VIII within the virion is better characterized than proteins 
IIIa and VI. Protein VIII is thought to stabilize the capsid since a temperature-sensitive 
mutant with a substitution mutation in protein VIII is more thermolabile than wildtype 
virus (65). A cryoEM analysis of adenovirus particles at ~10 Å resolution has provided a 
convincing assignment for protein VIII on the inner capsid surface (36). Protein VIII is 
known to be associated with hexons and is present in ~120 copies per virion (Table 1.1) 
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(123). Comparison of cryoEM structures of wild type Ad5, and a mutant virus lacking 
protein IX that had undergone single or multiple freeze/thaw cycles, enabled Fabry et al. 
to observe that there are two similar density regions per asymmetric unit on the inner 
capsid surface (36). These density regions were approximately the correct volume for 
protein VIII and in the correct copy number, which helped to support the assignment. 
Mass spectrometry indicates at least two adenovirus protease cleavage sites in the protein 
VIII precursor, leading to 7.6 and 12.1 kDa protein fragments in the mature virion (61). 
The precursor form of protein VIII has been found to be useful in reverse-phased HPLC 
analyses to quantitate the percentage of empty capsids in adenovirus preparations (125, 
135). This implies that mature adenovirus virion contains only the two cleaved fragments 
of protein VIII, with no remaining copies of the precursor form of protein VIII. 
 
Protein IX 
Protein IX is known as the “cement” that holds the capsid together. The main 
locations of protein IX within the virion were deduced by scanning transmission electron 
microscopy (STEM) of capsid dissociation fragments (40). Protein IX is present in 240 
copies per virion (Table 1.1), and four trimers of protein IX are known to stabilize the 
group of nine hexons in the center of each icosahedral facet. Protein IX is a relatively 
small capsid protein of 14.4 kDa, but recently it was shown to have at least two additional 
roles in adenovirus biology: protein IX is a transcriptional activator that enhances viral 
replication (98) and late in infection protein IX sequesters promyelocytic leukemia (PML) 
protein in clear amorphous nuclear inclusions (98, 99). PML proteins are the organizers 
of nuclear domains or PML bodies that participate in cellular antiviral responses (19). 
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Also, protein IX has gained prominence as a platform for ligand addition for the purposes 
of vector retargeting and fluorescence labeling (90). Thus, it is of interest to further 
investigate the location of protein IX and the other components within the adenovirus 
capsid. 
 
Aim I 
In Aim I, a subnanometer resolution cryoEM structure of adenovirus is 
determined. Ad35F was selected for this structural study due to its promise as a gene 
therapy vector targeted to hematopoietic cells and also because its short fiber is 
advantageous for cryoEM imaging. After using the hexon and penton base crystal 
structures to computationally remove hexon and penton base density from the EM map, 
the structure of the fiber and proteins IIIa, VI, VIII, and IX can be better characterized. In 
favorable cases, ~10 Å resolution is sufficient to resolve bundled α-helices. In the 9 Å 
resolution structure of Ad35F presented in Chapter III we resolved one α-helix on the 
capsid surface that was assigned to the C-terminal domain of protein IX. On the basis of 
this structural study we postulated that protein IX might have two alternate conformations 
either binding on the capsid surface or extending away from the capsid. This model is 
consistent with the tolerance of the C-terminus for inserted ligands and its potential use in 
vector retargeting. Well-defined density was assigned to the conserved N-terminal 
domain of protein IX required for incorporation into the virion. 
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Adenovirus cell entry and life cycle 
In modifying vector tropism, a detailed understanding of the cell entry process is 
required so that attachment to the host cell, internalization, and transfer of the genome to 
the nucleus remain intact. Adenovirus particles attach to host cells via characteristic 
fibers noncovalently extending from the penton base at the vertices. αvβ3 or αvβ5 integrins 
cluster at the penton base and initiate endocytosis (139). The fiber is thought to be 
released while the virion is still at the cell surface (81). Further viral dissociation occurs 
in the acidified environment of the endosome (47) and partial disassembly of the 
adenovirus capsid is required for membrane disruption (140). Protein IIIa is likely to play 
a role in cell entry as it is one of the earliest components released from the virion and one 
of the most thermally labile capsid components (47, 96, 140). Upon exposure to acidic 
pH, approximately 25% of hexons, the majority of penton bases, protein IIIa, and 80% of 
the internal capsid protein VI dissociate from the virion.  Protein VI possesses membrane 
lytic activity (140). The conformational changes that the adenovirus capsid must undergo 
in order to release protein VI are not well understood. Following membrane penetration, 
the partially disassembled virion travels to the nucleus via microtubules (62) and docks at 
the nuclear pore complex (NPC) where further disassembly occurs and the genome is 
transported to the nucleus (45).  
Transcription begins once the viral genome is imported into the nucleus. Early 
gene expression prepares the cell for viral replication. The immediate-early expressed 
products of the E1A and E1B genes activate transcription, induce S phase, and block 
apoptosis. The expression of the remaining early genes (E2, E3, E4, and VA) shuts down 
host mRNA transport and activates viral DNA replication. In the cytoplasm, the E3 gene 
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products result in immune evasion. Late transcripts produce the structural proteins needed 
for progeny virions (116). Viral assembly occurs in the nucleus, and protein VI regulates 
the nuclear import of hexons for assembly into virions (141). Viral DNA is packaged into 
preformed capsids with the assistance of protein IIIa and scaffolding proteins; however, 
the scaffolding proteins are released by the time mature virions are formed (44). The 
adenovirus cysteine protease cleaves numerous capsid and core proteins, thereby 
producing mature viral proteins. The proteolytic processing of precursor capsid and core 
proteins is necessary to produce infectious particles. Late in infection, high levels of the 
adenovirus death protein induces cell lysis and release of progeny virions (127).  The lack 
of an atomic resolution structure of an intact adenovirus virion has limited our 
understanding of the adenovirus cell entry process and life cycle and therefore hindered 
further vector development.  
 
Aim II 
The process of acid-induced disassembly and its relationship to protein VI release 
and lysis of the endosome may be further probed with a higher resolution structure of 
adenovirus. As the resolution of a density map improves α-helices resemble rods of 
density. Although ~10 Å resolution might be sufficient to resolve α-helices in favorable 
cases, many α-helical density rods are not fully resolved until ~7 Å resolution (56). Thus, 
in Aim II, a higher resolution structure of Ad35F is determined with the goal of 
identifying α-helices in the capsid proteins. Visualization of α-helices assisted the 
interpretation of capsid density remaining after the hexon and penton base density was 
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segmented and helped address how the locations of capsid proteins are linked to low pH-
induced capsid disassembly during cell entry. 
 
Selection of the technique for structure determination  
Structure determination by X-ray crystallography or solution state NMR works 
well for proteins that crystallize or for proteins that are less than 100 kDa in molecular 
weight, respectfully. Crystal structures have been solved for hexon (103), penton base 
(36), and portions of the fiber (13, 32, 133, 147); however, at least two of the four capsid 
components without atomic resolution structures are not soluble outside of the virion, 
which makes structure determination of individually expressed or purified capsid proteins 
difficult. Solving a high resolution structure of the intact adenovirus virion may be the 
only way to structurally characterize proteins IIIa, VI, VIII, and IX. Thus far, 
crystallography has not provided an atomic resolution structure for a virus as large as 
adenovirus, which has an icosahedral capsid 930 Å in diameter and a molecular mass of 
150 MDa. The largest viral structure solved by X-ray crystallography to date is simian 
virus 40 with a diameter of 500 Å and molecular mass of 14 MDa, which is 
approximately one tenth the mass of adenovirus (119). 
CryoEM is a powerful technique for structure determination of macromolecular 
complexes like adenovirus that are not amenable to other types of structural analyses. For 
cryoEM imaging, a small amount of the purified biological complex is flash frozen on a 
holey carbon grid in a thin layer of ice (2). The temperature is dropped below –140 °C so 
rapidly that vitreous or glass-like ice forms. Vitreous ice is not ordered like hexagonal ice, 
so the structure of the specimen is preserved in a near native-like state. There is no need 
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to crystallize the specimen because the random orientations of particles when frozen are 
advantageous for image processing.  
Major technological advances in imaging and computation have made 
subnanometer (<10 Å) resolution cryoEM structures attainable.  These advances include 
the commercial availability of the FEI Polara electron microscope, which is designed 
specifically for cryo work and has a specimen stage that is significantly more stable than 
electron microscopes with third party cryo-holders. With the Polara microscope specimen 
drift, which typically causes loss of high resolution information in cryo-micrographs, is 
kept to a minimum.  The Polara microscope also has a highly coherent electron beam 
produced by a field emission gun (FEG), and a high accelerating voltage (300kV), both 
of which contribute to producing cryo-electron micrographs with strong high resolution 
information. Advances in image processing include the ability to process large 3D 
volumes (up to 7503 voxels) and improved schemes for correcting the effects of the 
contrast transfer function (CTF) of the electron microscope. 
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CHAPTER II 
 
MATERIALS AND METHODS 
 
Gene delivery assay 
The Ad35F vector, with the Ad35 fiber, and the control Ad5F vector, with the 
Ad5 fiber, were prepared as described previously by Smith et al (117). The human acute 
monocytic leukemia cell line THP-1 was grown in RPMI 1640 medium supplemented 
with 10mM HEPES pH 7.55, 0.1mM non-essential amino acids, 4mM L-glutamine, 100 
units/ml penicillin G sodium, 100 μg/ml streptomycin sulfate and 10% fetal calf serum. 
Cells were plated at 4x104 cells/well in a 96 well plate. Ten microliters of virus were 
added to the 100 μl culture volumes in triplicate. After an overnight incubation at 37ºC, 
β-galactosidase activity was assayed using the Tropix Gal-Screen chemiluminescent 
reporter gene assay system (Applied Biosystems, Bedford, MA) according to 
manufacturer’s instructions using an equal volume of Buffer A for mammalian cells. 
Luminescence was read using an EG & G Berthold Microplate Luminometer LB96V 
(Perkin Elmer-Wallac Inc., Gaithersburg, MD) with a 1 sec time interval. 
 
Vitrification 
To remove the stabilizing agent, CsCl, small aliquots of purified Ad35F were 
dialyzed in 0.05 M Tris buffered saline (TBS) at pH 8.0 for 1 hour three times. pH 8.1 
was used to avoid pH-induced capsid dissociation. CryoEM grids were prepared using 
standard techniques (2). Briefly, 4 μl of purified, dialyzed Ad35F was applied to R2/4 
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Quantifoil holey carbon grids (Quantifoil Micro Tools GmbH) and flash frozen in ethane 
slush using a Vitrobot (FEI, Eindhoven, The Netherlands). Prior to plunging, a carbon 
layer was added to each side of the Quantifoil grid with the plastic film dissolved in 
between carbon layer applications to strengthen the grid support layer for imaging with 
the TF30 Polara electron microscope (FEI Company, The Netherlands). To reduce beam-
induced movements of the grid, the support layer was conditioned under an intense beam 
in a CM12 electron microscope overnight after the first carbon layer application.  
 
CryoEM imaging
Data collection was performed on an FEI Polara (300kV, FEG) electron 
microscope at liquid nitrogen temperature and 300kV with an UltraScan 4k x 4k CCD 
camera (Gatan Inc., Pleasanton, CA). Datasets 1 and 3 were collected in the nanoprobe 
imaging mode while dataset 2 was collected under the microprobe mode. Datasets 1 and 
2 were collected with an absolute magnification of 253,654X, and dataset 3 with 
397,878X. Leginon (124) was used for semi-automatic collection of dataset 2. Datasets 1, 
2, and 3 contained 1511, 4657, and 2015 micrographs, respectively. The microscope 
magnifications were determined to within +/-0.5% with a negatively stained TMV grid 
and later refined to within +/-0.25% during image processing for maximum correlation 
between the datasets and between the hexon coordinates (103) and the cryoEM density. 
The refined Angstrom-to-pixel ratio is 0.589 Å for datasets 1 and 2 and 0.375 Å for 
dataset 3 on the molecular scale without binning. 
 
 
 16
Three-dimensional image processing 
The entire dataset consisted of 6,880 particle images. Dataset 1 particle images 
(2214) were selected manually with QVIEW (112) and an automated particle picking 
program, Virus (1), was used for datasets 2 (2724 images) and 3 (1919 images). The 
automated routine CTFFIND3 (76) was used to determine the initial defocus and 
astigmatism parameters for each particle image. 
 
Initial refinement of Ad35F data for Aim I 
IMAGIC-5 reconstruction software was used for generation of the Ad35F 
structure at 8.9 Å resolution. This software does not include a mechanism to correct 
astigmatic particle images. Thus, particle images from dataset 1 with the greatest 
astigmatism (with a focal difference greater than 1,500 Å along the axis of astigmatism) 
were rejected from further processing. Through this mechanism the best 63% of the data 
was selected. The EMAN routine, applyctf, was used to flip phases using the defocus 
values determined by ctffind3, and thus partially correct for the contrast transfer function 
(CTF) of the microscope (66). An inverse temperature factor was not applied to the data. 
The IMAGIC-5 image processing software package was used to iteratively refine 
the centers of the particle images, determine angular orientations, and calculate three-
dimensional reconstructions (131). For any cryoEM dataset the best theoretically 
attainable resolution is twice the pixel size, termed the Nyquist limit. In practice, 
resolution better than three times the pixel size is rarely achieved. To achieve 
subnanometer resolution, or ~10 Å resolution, a pixel at least as fine as 3 Å should be 
processed. To speed up computation, the initial angular orientations were determined for 
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particle images binned to 2502 pixels (4.7 Å/pixel) and subsequently refined using 
particle images binned to 5002 pixels (2.4 Å/pixel). In the final round of image processing, 
particle images binned to 1,0002 pixels (1.2 Å/pixel) were used for refinement and then 
binned to 5002 pixels for calculation of the three-dimensional reconstruction (with 5003 
voxels, 2.4 Å/voxel). 
Phase residual-based sorting, similar to that performed by Borgnia et al. (8), was 
employed to select the best subset of particle images. Several times during refinement a 
phase residual was calculated between each particle image and its corresponding 
reprojection, which was calculated by projecting the reconstruction along the 
orientational angles determined for that particle image. The differential phase residual 
function in IMAGIC-5 was used for this purpose (130, 131). The data set exhibited a 
bimodal distribution of phase residuals. The subset of particle images with lower average 
phase residual values (82˚ to 94˚) were selected and independently reconstructed. This 
selection process improved the resolution by nearly 0.5 Å in the final round of refinement. 
The final reconstruction is based on 964 particle images. The resolution of the final 
reconstruction was assessed to be 8.9 Å by the Fourier shell correlation (FSC) method 
with the 0.5 correlation threshold (88). Inner and outer soft Gaussian masks, at radii 277 
and 465 Å respectively, were applied to the reconstruction so that the resolution 
determined would correspond to just the icosahedral virus capsid (121). This masking 
procedure removed the distal end of the fiber; however it did not remove any of the 
ordered density on the inner capsid surface.  
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High resolution refinement of Ad35F data for Aim II 
Similar to the processing of images in Aim I, particle images were binned to 2502 
pixels for the initial rounds of refinement, and subsequently binned to 5002 pixels for 
additional processing with a ~2 Å pixel size (2.36 Å for datasets 1 and 2, and 2.25 Å for 
dataset 3), and later binned to 7502 pixels for image processing with a 1.5 Å pixel size. 
The 9 Å resolution reconstruction of Ad35F (104) was used as a starting model for image 
processing with the FREALIGN v.7 program (49, 143). The FREALIGN code was 
modified to allow the input of angular and translational step sizes for refinement and the 
input of externally determined particle centers to aid in the initial determination of the 
orientational angles. The IMAGIC-5 (131) centering algorithm, Align, was used to 
determine initial particle centers.  
Multiple rounds of refinement were performed with FREALIGN, first with 
refinement of the five orientational parameters (3 angular and 2 translation), and later 
with additional refinement of the defocus and astigmatism parameters. The orientational 
angles were refined to within 0.0005° and X- and Y-centers to within 0.0025 pixels. No 
inverse temperature factor was applied to the data. Frealign can account for particle 
astigmatism in the reconstruction routine, so all the data was included for the purposes of 
orientational refinement. A phase residual cutoff of 85.5° was utilized to include only 
images with the highest correlation to the 3D reconstruction. During refinement the 
particle images were masked with an outer radius of 463 Å, which effectively cut off the 
fibers. For FSC resolution assessment, inner and outer masks at radii 300 Å and 463 Å 
were applied to prevent the inclusion of density from the disordered core and flexible 
fibers. Refinement was performed on an SGI Altix computer with 16-processors and 
 19
32GB of RAM, and on the Vampire 64-bit OS linux cluster at Vanderbilt. The final 
reconstruction was calculated from 2,630 particle images. 
 
Difference map generation
Difference mapping analyses were performed on the 6 and 9 Å resolution 
structures of Ad35F, but for Aim II a C-shell script (Gen_diffmap) was written to 
complete the difference mapping analysis in an automated fashion. First Gen_diffmap 
directed the docking of the hexon (103) and penton base (157) coordinates into 
subvolumes of the cryoEM map using the automated fitting tool, CoLoRes, in the Situs 
package (15). Gen_diffmap selected the best solutions corresponding to the four unique 
hexon positions within the asymmetric unit. The coordinates for a penton base monomer 
were extracted from the best solution for the penton base. Icosahedral symmetry was 
applied to the asymmetric unit to yield a pseudoatomic capsid of 240 trimeric hexons and 
12 pentameric penton bases. The pseudoatomic capsid was converted into a density map 
and filtered to 6.9 Å resolution (8.9 for Aim I) with the pdb2mrc routine in EMAN 
v1.7(66), normalized to the cryoEM density with the IMAGIC command Norm-Variance 
(131), and subtracted from the cryoEM map with the IMAGIC command Subtract-
Images in order to generate a difference map. The difference map contained density for 
the minor capsid proteins IIIa, VI, VIII, and IX, as well as small part of fiber associated 
with the penton base and regions of hexon and penton base missing from the crystal 
structures. Lastly the Gen_diffmap script extracted one eighth of the cryoEM 
reconstruction, the pseudoatomic map, and the difference map for visual inspection with 
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the UCSF Chimera package (92). Molecular graphics images were produced using 
Chimera and AVS5 (Advanced Visual Systems, Inc.) 
 
Volumetric analysis of capsid proteins 
When the 9 Å cryoEM reconstruction is contoured at 1σ, the adenovirus capsid 
surface appears continuous and there is essentially no noise. The volumes of various 
extracted density regions were assessed with a Fortran program (density_mult), which 
sums the volume of all of the voxels in the density region that have a density value equal 
to or greater than the specified contour level. For volume analysis of three regions in the 
structure determined in Aim I: the internal density associated with penton base; the large 
density lobe at the facet edge on the outer capsid surface; and the N-terminal third of 
protein IX, a contour level of 1 σ was used.  
 
Secondary structure prediction
The PsiPred server(12) was used to predict secondary structure for the sequences 
of the full-length precursor forms of the Ad5 proteins IIIa, VI, VIII, and IX, as well as the 
N-terminal 51 residues of the Ad5 penton base.  
 
Density segmentation, fitting of polypeptide models, and identification of protein 
interaction residues 
 
The Volume Eraser function of Chimera (92) was used for manual density 
segmentation. Canonical α-helices were built using Swiss PDB Viewer (50) for each 
length of helix 10 residues or longer predicted by PsiPred for protein IIIa. The α-helices 
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and 7-residue polypeptide models were manually positioned with Chimera into density 
rods in the cryoEM density.  
Potential protein-protein interaction residues between penton base and hexon in 
the pseudoatomic map and proteins IIIa in the cryoEM difference map were evaluated 
with Chimera (92). Protein IIIa density was displayed together with either the penton 
base or hexon coordinates. Penton base or hexon residues within 10 Å of protein IIIa 
were selected and saved to an output file. Some residues were eliminated as potential 
interaction residues because other residues blocked their ‘line-of-sight’ to protein IIIa.  
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CHAPTER III 
 
 
CRYO-EM STRUCTURE AT 9 Å RESOLUTION OF AN ADENOVIRUS 
VECTOR TARGETED TO HEMATOPOIETIC CELLS 
 
 
 
Aim 
Apart from the density assignments in the first adenovirus difference map at 25 Å 
resolution (123), very little is known structurally about capsid proteins IIIa, VI, VIII, and 
IX. The goal of Aim I was to characterize the capsid components without known atomic 
resolution structures by determining an intermediate resolution cryoEM structure of 
adenovirus. A subnanometer resolution structure should allow a detailed volumetric 
analysis of capsid density remaining after the hexon and penton base are computationally 
removed.  This chapter was published as a manuscript in the Journal of Molecular 
Biology (104).  
 
Experimental design 
The vector (Ad35F) used in the study is composed of the Ad5 capsid pseudotyped 
with the Ad35 fiber. Adenovirus fibers are composed of a variable number of β-spiral 
motifs called β repeats. The Ad35F vector is ideal for a cryoEM study because the Ad35 
fiber has only 5 and a half β-spiral repeats compared to 22 β-spiral repeats in Ad5. This 
shorter fiber should allow a thinner layer of ice around the adenovirus particle, which 
should in turn produce cryo micrographs with the best signal-to-noise ratios. Ad35F is 
interesting for structural analyses since it shows promise in vector retargeting to non-
CAR expressing cells including hematopoietic cells. Non-hexon and non-penton base 
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density is visualized by a difference mapping approach where a pseudoatomic capsid of 
240 hexons and 12 penton bases is subtracted from the cryoEM map. By volumetric 
analysis together with modeling studies, the minor capsid components are further 
characterized.  
 
Adenovirus vector gene delivery to hematopoietic cells
Most adenoviral vectors used in gene therapy applications are derived from the 
common Ad5 serotype, which infects a broad range of cells and normally causes a mild 
respiratory infection. A panel of adenovirus vectors based on the Ad5 serotype was 
generated with various mutations in the fiber and penton base and these were screened for 
in vivo gene transfer in mice (117). One vector, Ad35F, was selected for a high resolution 
cryoEM structural analysis on the basis of its short fiber and gene delivery potential. This 
vector is composed of the entire icosahedral capsid of Ad5 with the exception of the 
Ad35 fiber. Ad35F increased gene delivery to human monocytic cells ~100 fold 
compared to the same vector with the Ad5 fiber (Ad5F) (Figure 3.1). Ad5 normally 
utilizes CAR for host cell infection, while Ad35 uses CD46. This result supports the 
emerging concept that the CD46-utilizing fibers play a major role in promoting infection 
of human hematopoietic cells (114).  
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Figure 3.1. Gene delivery by Ad35F to a leukemia cell line. THP-1 cells were incubated 
overnight in triplicate wells (4x104 cells/well) of a 96 well plate without or with 
increasing concentrations of Ad35F (solid) or Ad5F (dashed) containing the β-
galactosidase gene. Infection, determined by increased β-galactosidase activity, was 
assayed using the Tropix Gal-Screen chemiluminescent reporter gene assay system and 
read using an EG & G Berthold Microplate Luminometer LB96V. Data points are means 
of triplicate wells ± SD. Figure reprinted from (104) with permission from Elsevier. 
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CryoEM structural analysis of Ad35F
 Relatively few virus structures have been determined to better than 10 Å 
resolution by cryoEM methods and adenovirus is one of the largest of these (155). In 
order to achieve high resolution for adenovirus, cryoelectron micrographs were collected 
on an FEI Polara microscope and image processing was performed on a parallel 
computing cluster. The final data set of the best 964 Ad35F particle images produced a 
reconstruction at 8.9 Å resolution (Figure 3.2). The diameter of the icosahedral capsid 
measured along a 5-fold symmetry axis is ~927 Å. If the protruding fiber is considered 
including the weak density from the fiber knob, then the diameter along a 5-fold axis is 
~1,191 Å. Evaluation of the cryoEM density for this large and complex virus was greatly 
aided by several factors: the crystal structures of the Ad5 hexon (103) and Ad2 penton 
base (157) with 98% sequence homology to the Ad5 penton base, an earlier cryoEM 
difference map analysis of Ad2 (123), and knowledge of the stoichiometry of the capsid 
proteins (61).  
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Figure 3.2. CryoEM structure of Ad35F. (a) The pseudo-atomic capsid formed by 240 
copies of the trimeric hexon and 12 copies of the pentameric penton base shown filtered 
to 9 Å resolution and viewed along an icosahedral 3-fold axis. (b) CryoEM difference 
density (radially color coded) together with the pseudo-atomic capsid (gray) in the same 
view as in part (a). Bar, 250 Å. (c) A Fourier shell correlation (FSC) plot indicating a 
resolution of 8.9 Å at the 0.5 threshold (red) and 8.1 Å at the 0.3 threshold (blue). Figure 
reprinted from (104) with permission from Elsevier. 
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CryoEM density for hexon and associated internal density 
The Ad5 hexon crystal structure is missing 60 residues due to disorder, and all but 
9 of these are on the exposed top of the hexon (103). Figures 3.3a and 3.3b show cryoEM 
density for one of the three towers at the top of a hexon next to an icosahedral 3-fold axis. 
The crystallographic coordinates for this region are also displayed with the missing 
residues and sidechain atoms in this region indicated. In the difference map calculated 
between the Ad35F cryoEM reconstruction and the pseudo-atomic capsid, there is 
difference density at the top of each hexon. In addition to the difference density at the top 
of the hexon, there are also small patches of difference density on the hexon sides that 
match regions where only sidechain atoms are missing from the crystal structure.  
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Figure 3.3. CryoEM hexon density. (a) Side view of one tower from a hexon next to an 
icosahedral 3-fold axis. The cryoEM density (mesh) encloses the tower coordinates from 
the docked Ad5 hexon crystal structure (PDB 1P30) (103) (ribbon). The residues in the 
tower region that are missing from the crystal structure are represented by red gaps, and 
the residues with missing sidechain atoms are represented in green. (b) A 90˚ rotated 
view of the cryoEM density and docked hexon coordinates colored as in part (a). (c) 
CryoEM difference density at the top of the same hexon shown radially color coded with 
labels indicating the general locations of hypervariable regions (HVRs) 1, 2, 4, 5, 8, and 9 
that contribute to the difference density. (d) The cryoEM hexon density (mesh) and the 
Ad5 hexon tower coordinates (ribbon) colored as in parts (a) and (b) with the residues 
near the epitope of a neutralizing antihexon antibody (9C12). Epitope proximal residues 
178 and 179 from the DE1 loop (magenta) and residues 430 and 437 from the FG1 loop 
at either end of a gap (red) are shown as spheres. The hexon is rotated slightly more that 
90˚ with respect to part (a) so that the density protrusion (arrow) near the 9C12 epitope is 
clearly visible. (e) Bottom view of the hexon trimer coordinates docked into position H2 
displayed with the associated internal cryoEM difference density (green). The U-shaped 
difference density lining one side of the hexon cavity is indicated. The first and the last 
ordered hexon residues near the N- and C-termini are shown as blue and red spheres, 
respectively. The residues implicated in protein VI binding (aa 770 - 787) are shown in 
magenta. Figure reprinted from (104) with permission from Elsevier. 
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Many of the gap regions in the hexon crystal structure correspond to 
hypervariable regions (HVRs) between hexons of various adenovirus serotypes, which 
include type-specific epitopes (28, 103). We have labeled the difference density at the top 
of the hexon in terms of these HVRs (Figure 3.3c). The missing region (aa 136-164) that 
roughly corresponds to HVR1 (aa 138-166) is quite long. Therefore HVR1 might cover a 
large surface area on the top of the hexon. At this resolution it is not possible to precisely 
delineate the boundaries of the HVRs. However, the wide wing-shaped hexon density 
observed in the cryoEM difference density clearly includes missing residues and 
sidechain atoms from HVRs 1, 2, 5, 8 and 9. In addition a separate lobe of density is 
observed on side of the hexon tower corresponding to missing residues (aa 251-256), 
which overlap with HVR4 (aa 253-257).  
The hexon difference density most likely includes the epitope recognized by the 
9C12 neutralizing monoclonal antibody, which has been visualized in complex with Ad5 
by cryoEM (134). In this previous study, hexon residues 178 and 179 as well as residues 
from the FG1 loop were identified as close to the center of the epitope. However the 
moderate resolution (21 Å) of the cryoEM structure of the Ad5/9C12 complex did not 
allow a precise identification of the epitope. The 9 Å resolution Ad35F cryoEM structure 
shows a density protrusion near the epitope proximal residues that is likely to contain the 
actual epitope for 9C12 (Figure 3.3d). This density protrusion is most likely formed by 
residues from the gap of aa 431-436, which includes HVR8 from the FG1 loop, and 
possibly by residues from the long gap of aa 136-164, which includes most of HVR1.  
On the inner capsid surface a significant amount of difference density was 
observed below each hexon (Figure 3.3e). The hexon crystal structure is missing 4 
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residues at the N-terminus and 5 residues at the C-terminus, both of which are located 
near the bottom of the hexon, however the difference density is much larger than 
expected for these residues. A U-shaped region of difference density appears to line one 
side of the hexon cavity and connects with a large density lobe below the interface 
between several hexons. The U-shaped density comes within 10 Å of the hexon residues 
thought to be involved in interactions with protein VI (72, 141). 
 
Penton base integrin-binding loop, variable loop, and associated internal density 
The Ad2 penton base crystal structure is missing ~80 residues in the integrin-
binding RGD loop due to disorder (157). Since the Ad2 and Ad5 penton base sequences 
are highly homologous (98% identity), the Ad2 penton base crystal structure fit well 
within the cryoEM reconstruction of Ad35F, which has the Ad5 penton base. CryoEM 
density from five RGD loops is clearly visible protruding above the penton base (Figure 
3.4a). In addition, five copies of a second penton base surface loop are also observed in 
the difference map. This region corresponds to the variable loop on the side of the penton 
base (aa 142-169 in Ad2 and Ad5) that is present in the crystal structure as an extended β 
ribbon. The observation of cryoEM density for this surface loop, despite the fact that it is 
in the crystal structure, indicates that this loop is flexible. 
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Figure 3.4. CryoEM penton base density. (a) Tilted view of the penton base and fiber 
difference density. Density regions corresponding to the fiber, penton base RGD loop, 
and variable loop are indicated. The difference density is radially color coded as in Figure 
3.2a. (b) Internal capsid density below the penton base. The N-terminal five residues (aa 
52-56) in the penton base crystal structure (PDB 1X9T) (157) are shown as red density, 
which is only partially visible at the bottom of the penton base. Bars, 50 Å. Figure 
reprinted from (104) with permission from Elsevier. 
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In addition to the density on the outer surface of the penton base, there is also 
cryoEM difference density below the penton base on the inner capsid surface (Figure 
3.4b). Five density spokes extend ~50 Å into the viral core. The penton base crystal 
structure was determined for an N-terminal truncation missing the first 48 residues. The 
first ordered residue present in the crystal structure is at the bottom of the penton base. 
Thus, the cryoEM density observed below the penton base probably includes the missing 
N-terminal tails. Volume analysis indicates that an additional ~20 kDa of mass is 
associated with each penton base N-terminal tail.  
 
Ad35 fiber flexibility 
 CryoEM difference density is observed for the fiber at each capsid vertex. 
Negative stain EM and fiber sequence alignment suggested that the fibers of some 
adenovirus serotypes are flexible due to variations in the fiber shaft repeat sequence (24). 
This concept was supported by the crystal structure of a portion of the Ad2 fiber shaft, 
which further elucidated the residues important for the fiber shaft triple β-spiral fold 
(133). Analysis of the Ad35 fiber sequence revealed five and a half repeats; however, 
repeat number 3 deviates from the consensus and is predicted to be flexible (Figure 3.5a). 
The observed cryoEM density for the Ad35 fiber is in agreement with this prediction as 
the fiber shaft density appears discontinuous and the fiber knob density is weak (Figure 
3.5b and 3.5c). 
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Figure 3.5. Ad35 fiber density. (a) Alignment of the five and a half repeats in the Ad35 
fiber shaft colored as by van Raaij et al.(133): with the conserved hydrophobic residues 
in the core in orange; the residues forming an external patch in green; and the conserved 
proline or glycine in purple. The two consensus patterns are shown below. (b) Side view 
of the Ad35F vertex region including a penton base and fiber. The fiber shaft appears 
discontinuous presumably because repeat 3 is flexible. (c) The Ad35F vertex region 
shown filtered to 24 Å and with a lower isosurface to include weak density for the fiber 
knob (bracket). Bar, 50 Å. Figure reprinted from (104) with permission from Elsevier. 
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The crystal structure of the Ad2 penton base/fiber peptide complex shows that 11 
residues (aa 10-20) of the N-terminal fiber tail lie in a groove on the top of the penton 
base (157). Therefore, the homologous region in the Ad35 fiber would likely contribute 
no appreciable length to the reconstructed fiber. The length of a triple β-spiral repeat is 13 
Å (133). There is currently no atomic resolution structural information for the sequence 
between the penton base binding peptide and the first repeat (aa 21-43 in Ad35). Since 
this region is approximately the same number of residues as in one fiber shaft repeat, we 
estimate that it has approximately the same height, 13 Å. For the half repeat at the C-
terminal end of the shaft we estimate 6 Å. Thus, we predict that the reconstructed Ad35 
fiber shaft should be 84 Å long, in excellent agreement with the measured length of 85 Å.  
When the reconstruction is filtered to 24 Å and shown with a lower isosurface to 
include weak density, density is observed for the fiber knob (Figure 3.5c). However, the 
knob appears wider than expected from the knob crystal structures (13, 32, 132, 147). 
This widening is likely due to the flexible Ad35 fiber shaft that results in smeared, weak 
reconstructed density for the knob. The height of the fiber knob, as measured from the 
knob crystal structures, is ~50 Å. Therefore we would predict a length of 134 Å (84 Å for 
the shaft plus 50 Å for the knob) for the full length Ad35 fiber. This is in good agreement 
with the fiber length of 132 Å as measured in the 24 Å filtered Ad35F reconstruction. 
The adenovirus capsid has a well characterized symmetry mismatch between the 
trimeric fiber and the pentameric penton base. In the icosahedral cryoEM reconstruction, 
5-fold symmetry has been imposed on the trimeric fiber effectively blurring the fine 
features of the fiber. So although the crystal structure of the fiber shaft revealed a 
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distance of 13 Å and a rotation of ~50° from one repeat to the next within a single fiber 
polypeptide (133), we would not expect to observe these features in the reconstruction.   
 
Additional hexon associated density 
In an earlier cryoEM difference map analysis of Ad2 at ~25 Å resolution, large 
discrete regions on the outer capsid surface were assigned to protein IIIa, with two copies 
along each icosahedral 2-fold edge for a total of 60 copies within the virion (123). These 
same density lobes are apparent in the 9 Å resolution difference map between hexons of 
two different facets (Figure 3.6a). The HVR4 loop of one neighboring hexon interacts 
with this large density lobe (Figure 3.7a). Volume analysis indicates that the large density 
lobe corresponds to ~27 kDa, which is approximately half of the molecular mass of the 
mature form of protein IIIa (63 kDa) (61). 
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Figure 3.6. N-terminal domain of protein IX. (a) A region of the cryoEM difference 
density that roughly corresponds to an icosahedral facet. A small portion of fiber (red) is 
visible in the three corners of the image. Trimeric density assigned to the N-terminal 
domain of protein IX (cyan) is outlined at the icosahedral 3-fold axis (in black) and at 
three local 3-fold axes (in white). White rectangles outline the density assigned to the C-
terminal region of protein IX (green), which is partially occluded by the peripentonal 
hexons. A large density lobe near the facet edge, which is tentatively assigned as a 
significant portion of polypeptide IIIa, is marked with an asterisk. Crystallographic 
symbols indicate the icosahedral 2-fold (black oval), 3-fold (black triangle), and 5-fold 
(black pentagon) symmetry axes. (b) Top view of the trimeric density assigned to three 
copies of N-terminal domain of protein IX extracted from the icosahedral 3-fold region. 
(c) Top view of the same density together with three nearby hexon HVR2 regions (green) 
and weak density (transparent cyan) extending outward from the trimeric density to the 
hexon HVR2 regions. (d) Side view of the protein IX and hexon density shown in part (c). 
The weak density is fitted with a model for the N-terminal 7 residues of protein IX. Bars, 
50 Å. Figure reprinted from (104) with permission from Elsevier. 
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CryoEM density for protein IX 
Mass spectroscopy has confirmed that there are ~240 copies of protein IX within 
the adenovirus capsid (61). Density was assigned to protein IX by cryoEM difference 
mapping (123) on the basis of an earlier Scanning Transmission Electron Microscopy 
(STEM) study (40). Trimeric protein IX density was observed in the 9 Å resolution 
cryoEM difference map in the same four locations per facet as previously observed 
(Figure 3.6a). The trimeric density region at the icosahedral 3-fold axis was extracted 
(Figure 3.6b) and its volume indicates a mass of ~8 kDa at 1σ. The similar trimeric 
density region at the local 3-fold axis was also extracted and its volume indicates a mass 
of ~12 kDa at 1σ. The larger volume corresponds well with that predicted for three copies 
of a domain identified in the N-terminal third of protein IX that is highly conserved 
among human and animal adenoviruses and includes residues crucial for incorporation of 
protein IX into the virion (98). Thus, we propose that the trimeric density corresponds to 
three copies of the conserved virus interaction domain of protein IX (aa 8-39). 
Weak density was observed extending outward from the trimeric protein IX 
density (Figure 3.6c and 3.6d). This density is the correct length to correspond to an 
extended 7 residue polypeptide chain. Similar weak density was also observed above the 
local 3-fold trimeric density regions. We propose that the weak density corresponds to the 
N-terminal 7-residues of the Ad5 protein IX, which immediately precede the conserved 
virus interaction domain. We note that three hexon HVR2 loops are directly over the N-
terminal protein IX density (Figure 3.6c and 3.6d). This may explain why the N-terminal 
domain of protein IX appears to be shielded from antibodies in immunoelectron 
microscopy studies (3). 
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It has been noted that the middle third of the protein IX sequence contains an 
alanine-rich region (aa 60 to 72) that might be flexible, and that the C-terminal third has a 
predicted coiled coil (98). We submitted the Ad5 protein IX sequence to the MultiCoil 
web server (142) and found that a dimeric coiled coil is predicted for 39 residues (aa 97-
135) with a high probability (0.86 - 0.99). Thus we searched the cryoEM difference 
density for any region that might correspond to a coiled coil. Other cryoEM structures 
have demonstrated that at 9 Å resolution it is possible to resolve bundled α-helices (26). 
We found density that might correspond to a single 39-residue α-helix located between 
two peripentonal hexons (Figure 3.7a). No well-defined difference density was found that 
might correspond to a dimeric coiled coil of this length. The only other similar rod-
shaped density in the difference map was near the 2-fold symmetry axis; however, it was 
not as well defined.  
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Figure 3.7. C-terminal domain of protein IX. (a) A region of the cryoEM difference 
density including a penton base, two peripentonal hexons (H1), one hexon in position 
four (H4), rod-shaped density assigned to the C-terminal predicted α-helix of protein IX 
(green, outlined with a white rectangle), and nearby protein IX N-terminal density (cyan, 
outlined with a white triangle). The asterisk marks the density assigned to a portion of 
polypeptide IIIa and the round dot indicates the interacting HVR4 loop from a 
neighboring hexon. Crystallographic symbols are shown as in Figure 3.6a. Bar, 50 Å. (b) 
A side view of the rod-shaped density (transparent green) fitted with a model for a 39-
residue α-helix (black) as predicted for protein IX residues 97-135. Arrows mark the 
teardrop-shaped density lobe assigned to the C-terminal 5-residues (aa 136-140) 
following the predicted α-helix. Figure reprinted from (104) with permission from 
Elsevier. 
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The rod-shaped density between the peripentonal hexons has a teardrop-shaped 
region at one end that is similar in shape and size, or just slightly smaller than the hexon 
HVR4 protrusion. We assigned the hexon HVR4 density lobe to a 6-residue gap in the 
hexon crystal structure. Thus, it is reasonable to assume that the teardrop-shaped region 
corresponds to approximately 5 or 6 residues. A model for a 39-residue α-helix fits nicely 
within the rod-shaped density (Figure 3.7b). No other capsid protein has a predicted α-
helix of 39 residues or longer. Therefore, we propose that the rod-shaped density 
corresponds to a single copy of the protein IX predicted α-helix (aa 97-135), and that the 
teardrop-shaped density at the end corresponds to the C-terminal 5 residues (aa 136-140). 
There is some weak difference density that might correspond to the flexible midsection of 
protein IX spanning half of gap between the assigned N- and C-terminal portions of 
protein IX.  
 
Discussion
Here we present a subnanometer resolution structure of the Ad35F vector. This 
vector is ~100 fold more efficient at gene delivery to human monocytic cells than the 
Ad5F vector, which differs only in its displayed fiber protein. The fibers of the various 
adenovirus serotypes vary in length and flexibility, which has been demonstrated to affect 
attachment receptor usage and cell tropism (115, 144). The cryoEM reconstruction shows 
that the Ad35 fiber is flexible, as predicted by sequence analysis. In particular repeat 3 of 
the Ad35 fiber shaft has an insert of four residues that likely disrupts the β-spiral fold. It 
has been noted that the third repeat in most adenovirus serotypes, except those of 
subgroup D, has a nonconsensus sequence and is likely to induce flexibility in the fiber 
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shaft (145). We have previously reconstructed the full length of a subgroup D (Ad37) 
fiber, which indicates that it is rigid and straight (23). Both Ad35 (subgroup B) and Ad37 
(subgroup D) utilize CD46 as the attachment receptor. However, Ad37, but not subgroup 
B Ads, has a strict requirement for calcium ions for efficient CD46 interaction (109, 146). 
Together with the observed difference in flexibility between the Ad35 and Ad37 fiber 
shafts noted in this study, these findings suggest that subgroup B and D adenoviruses 
have differences in receptor engagement. Our recent studies show that both viruses 
require the CD46 short consensus repeats SCR1 and SCR2, but they could bind to 
different sites within these domains and with different affinities (L. Pache and G.R. 
Nemerow, unpublished results). 
By positioning the hexon and penton base crystal structures within the 9 Å 
resolution cryoEM density of Ad35F, a pseudo-atomic model for a capsid of 240 hexon 
trimers and 12 penton bases was generated. This calculated capsid was subtracted from 
the cryoEM density to produce a difference map that revealed density from numerous 
surface loops of hexon and penton base. In comparing the cryoEM and x-ray structures, 
we used the atomic models of hexon and penton base, rather than the crystallographic 
electron density maps. If we had used the crystallographic electron density maps, we 
suspect that the cryoEM and crystallographic structures would have appeared more 
similar. We analyzed the difference density on top of the hexon in terms of the gaps in 
the crystal structure and found that these density regions correspond to several antigenic 
hypervariable regions. In addition, this high resolution cryoEM analysis enabled us to 
predict with higher accuracy the epitope region of the 9C12 neutralizing monoclonal 
antibody, studied earlier at only moderate (21 Å) resolution (134). Remarkably, 
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difference density was observed for numerous sidechains over the surface of hexon, 
including those of the hypervariable HVR2 loop that were disordered in the crystal 
structure. Difference density was also found for the integrin-binding RGD loop and the 
variable loop on the side of the penton base. The variable loop is actually present in the 
crystal structure and thus our result indicates that it is flexible and occupies a larger 
volume than would be expected for a rigid loop. This loop has been proposed as a 
possible site for vector retargeting insertions (36). This cryoEM study suggests that 
insertions could be tolerated at this point within the adenovirus capsid, especially if a 
flexible linker region were added.  
The cryoEM difference map should include the ordered portions of the minor 
capsid proteins. The earlier moderate resolution cryoEM difference map analysis 
suggested that protein IIIa, or at least part of IIIa, is on the outer capsid surface along the 
edges of the icosahedral facet (123). A similar density lobe is found on the outer capsid 
surface in the 9 Å resolution difference map, which could account for approximately half 
of the mature form of protein IIIa. In addition, we have found internal density associated 
with hexons and with the penton base. The density below the penton base might 
correspond to protein IIIa, VI, or VIII or perhaps to the adenovirus protease. The copy 
number is correct for protein IIIa, with 60 copies per virion (61). Volume analysis 
indicates that it might be one domain of the 63 kDa mature form of protein IIIa. This 
location for protein IIIa would be consistent with the finding that penton base and protein 
IIIa are the most thermally labile components of the virus (96). It would also be 
consistent with the Argon plasma etching result indicating that protein IIIa is located 
between the capsid and the core (82). Additional information will be needed to position 
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protein IIIa within the capsid. We speculate that the internal density associated with 
hexon might correspond to protein VI, since it approaches the hexon residues implicated 
in protein VI binding (72, 141). If the minor capsid components are partially or fully 
disordered and do not follow the icosahedral symmetry of the virion, they will be difficult 
to definitively locate.  
Immunoelectron microscopy indicates that the C-terminus of protein IX, but not 
the N-terminus, is accessible on the viral surface (3). In addition, several groups have 
successfully attached domains to the C-terminus of protein IX and incorporated these 
fusion proteins into adenovirus vectors (90). The cryoEM structural analysis presented 
here has led to a more complete model for the location of protein IX within the 
adenovirus capsid (Figure 3.8). Four trimeric regions of cryoEM density were observed 
within an icosahedral facet in the sites traditionally thought to be the protein IX binding 
sites. Volume analysis suggested that this density corresponds only to the N-terminal 
conserved domain of protein IX known to be crucial for capsid association. The cryoEM 
density also reveals weak density above this domain that is the right size for the N-
terminal, presumably flexible, 7 residues. The locations we have proposed for all twelve 
copies of the N-termini of protein IX within the icosahedral facet are shielded by hexon 
HVR2 lobes and thus would not be accessible to antibodies, in agreement with the 
immunoelectron microscopy results. 
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Figure 3.8. Diagram of protein IX within an icosahedral facet. (a) The positions of N- 
and C-termini are indicated; the conserved N-terminal region (aa 8-39) is symbolized by 
an oval outline; the flexible midsection (aa 44-96) by a dashed line; and the predicted C-
terminal α-helix (aa 97-135) by a helix. Three copies of the C-terminal α-helices are 
proposed to bind on the capsid surface near the icosahedral 5-fold axes. Well-defined 
density is not observed for the other C-terminal domains and these may extend outward 
from the capsid surface. The four unique hexon positions within the asymmetric unit are 
labeled H1 through H4. Crystallographic symbols are shown as in Figure 3.6a. (b) Side 
view of the two proposed protein IX conformations: with the C-terminal α-helix binding 
on the capsid surface (left), and with the C-terminal α-helix extending outward from the 
capsid surface (right). Figure reprinted from (104) with permission from Elsevier. 
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The cryoEM density suggests that three of the twelve copies of protein IX within 
one facet have their C-terminal domains binding on the capsid surface. We found well-
defined rod-shaped density between peripentonal hexons that agrees with a single 39-
residue α-helix with a loop of 5 residues at the extreme C-terminus. There is no well-
defined difference density that can be easily assigned to the C-terminal domains of the 
other nine copies of protein IX within one facet. Therefore, we propose that the flexible 
alanine-rich midsection may allow protein IX to adopt two different conformations 
(Figure 3.8b). Perhaps some of the protein IX C-terminal domains bind to the capsid and 
others extend away from the capsid surface and are not reconstructed. It is possible that 
pairs of extended C-terminal domains form coiled coils above the capsid surface. An 
extended conformation for some copies of protein IX would make these C-termini 
accessible to antibodies and provide plenty of space for large C-terminal additions. 
The 9 Å resolution cryoEM structure of adenovirus provides a wealth of new 
knowledge for this human pathogen, which is also recognized as important for potential 
gene therapy and vector-based vaccine applications. In particular this structural 
investigation has provided insight into the flexible regions of the three major capsid 
proteins, hexon, penton base and fiber. In addition, protein IX is proposed to have some 
flexibility and this property may be advantageous for its use as a platform for ligand 
additions. This study has also shown that not all of the adenovirus capsid components 
follow strict icosahedral symmetry. Perhaps flexibility in the adenovirus capsid is 
essential for proper assembly and maturation, in addition to receptor engagement during 
cell entry. 
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CHAPTER IV 
 
VISUALIZATION OF α-HELICES IN A 6 Å RESOLUTION CRYO-EM 
STRUCTURE OF ADENOVIRUS ALLOWS REFINEMENT  
OF CAPSID PROTEIN ASSIGNMENTS 
 
 
Aim
Three points were unaddressed following the cryoEM structural analysis of Aim I: 
(1) the location of the predicted coiled coil of protein IX; (2) the location of half of the 
protein IIIa density; and (3) the identity of the density associated with the penton base 
along the inner capsid surface. To help address these questions, the objective of Aim II 
was to solve a high resolution structure of Ad35F in order to visualize α-helices as 
density rods. We reasoned that if α-helices were resolved as rods in capsid proteins with 
known atomic structures such as penton base and hexon, then α-helices could be 
identified in other capsid density. We hoped to use this information in conjunction with 
α-helical predictions for proteins IIIa, VI, VIII, and IX to interpret capsid density with 
greater confidence than was possible at lower resolutions. This chapter is an expanded 
version of a paper in press in the Journal of Virology (105). 
 
Experimental design 
The resolution of the first Ad35F structure leveled-off at 9 Å, so additional 
datasets were necessary to refine the structure to higher resolution. In order to increase 
the number of images in the reconstruction by approximately four-fold, dataset 2 was 
collected with the Leginon semiautomated data acquisition software package (124). The 9 
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Å resolution structure of Ad35F was calculated from images collected with a nominal 
magnification of 200,000 and a pixel size of 0.6 Å at the specimen level. Since this data 
was collected on a CCD camera, the most efficient data transfer occurred between low 
resolution and ~9 Å, which could be a factor limiting the resolution of the first structure 
of Ad35F.  Shifting to a higher magnification like 310,000 (0.38 Å/pixel) extends the 
efficient information transfer region to ~6 Å. Thus, dataset 3 was collected at 310,000X 
to amplify 6 Å information in the reconstruction.  
For the 9 Å resolution structure of Ad35F, the most astigmatic images were 
excluded from processing and the three-dimensional structure. The astigmatism in the 
remaining images, though less in magnitude, was simply ignored. This could be another 
factor limiting the resolution, so we employed a second image processing program, 
Frealign (Fourier Reconstruction and Alignment), which takes the astigmatism of each 
image into account when correcting for the contrast transfer function (CTF) imposed by 
the microscope. 
Since the goal of Aim II is to resolve α-helices, we strove to extend the resolution 
of the Ad35F reconstruction to the range of 5 – 7 Å. By the Nyquist Theorem, 5 Å 
resolution is possible if the pixel size is at most 2.5 Å; however, resolution better than 
three times the pixel size is rarely achieved. In our case when we binned the particle 
images to 5002 pixels, three times the pixel size (2.4 A) is 7.2 Å.  When the resolution of 
the reconstruction reached ~7 Å, dataset 3 was rebinned from the original micrographs to 
7502 pixels and processed with a finer pixel size (1.5 Å) in order to facilitate extension of 
the resolution out to possibly 4.5 Å. The size of the reconstructed volume was then 7503 
voxels, which necessitated using ~20 GB of memory (RAM) for image processing with 
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Frealign. This extremely large memory requirement dictated that the final processing had 
to be performed on an SGI Altix computer equipped with 32 GB of RAM.  
 
CryoEM structure at 6Å resolution reveals α-helices 
The cryoEM structure of Ad35F at 9 Å resolution provided new information 
about the capsid proteins, particularly for protein IX, but a complete assignment was not 
possible for the additional capsid proteins (104). Acquisition of more particle images 
(6,880 vs. 2,215 total), inclusion of more particle images in the final reconstruction 
(2,630 vs. 964), and improvement in the image processing methods has enabled us to 
extend the resolution and enhance our interpretation of adenovirus structure (Figure 4.1). 
The resolution of the new Ad35F reconstruction as assessed by the conservative 0.5 
Fourier shell correlation (FSC) threshold is 6.9 Å (Figure 4.1b). Information extends to 
6.1 Å as indicated by the 0.3 FSC threshold.  
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Figure 4.1. CryoEM structure of Ad35F at 6 Å resolution. (a) Surface view along a 2-
fold symmetry axis of the reconstruction. The density is radially color-coded (red = 596Å; 
blue = 316Å). The flexible fibers were masked during image processing and only a short 
portion of the fiber is reconstructed. (b) A Fourier shell correlation (FSC) plot indicating 
a resolution in the range of 6.1 to 6.9 Å, at the 0.3 and 0.5 thresholds respectively. (c) 
Hexon (PDB 1P30) (103) and penton base coordinates (PDB 1X9T) (157) for one 
asymmetric unit of the capsid after docking within the cryoEM density. The penton base 
monomer is in yellow, hexon in position 1 in green, position 2 in cyan, position 3 in blue, 
and position 4 in magenta. (d) Pseudoatomic capsid calculated by applying icosahedral 
symmetry to the asymmetric unit. Scale bars, 50 Å. Figure reprinted from (105) with 
permission from the American Society for Microbiology. 
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The 6 Å resolution map enabled a more accurate fitting of the atomic resolution 
structures of hexon (103) and penton base (157) within the cryoEM density with the 
CoLoRes quantitative docking tool in the Situs software package (15). In particular the 
magnification was refined to within +/-0.25% by fitting with the hexon crystal structure, 
whereas at 9 Å resolution the magnification could only be refined to within +/-2.0% by 
this method. After docking the hexon and penton base crystal structures into the cryoEM 
density, we generated coordinates for the asymmetric unit of the adenovirus capsid 
including four independent hexon trimers and one monomer of the penton base (Figure 
4.1c). Application of icosahedral symmetry to the asymmetric unit produced a 
pseudoatomic model for the adenovirus capsid containing all 240 copies of the hexon 
trimer and 12 copies of the pentameric penton base, representing over 5.2 million non-
hydrogen atoms (Figure 4.1d).  
The 6 Å resolution reconstruction is significant in that α-helices longer than 10 
amino acids are now resolved within the icosahedral capsid. The backbone of a 10 
residue α-helix has nearly three complete helical turns, and this is long enough to produce 
a rod-like shape that is recognizable at 6 Å resolution (55). Surface representations of the 
major capsid proteins penton base and hexon also reveal finer detail than observed in the 
9 Å resolution map (Figures 4.2a and 4.3a). The Ad35 fiber was previously noted to be 
flexible (104), and therefore it was masked during image reconstruction. Thus, only a 
short portion of the fiber shaft is visible protruding from the penton base in the 
reconstruction (Figure 4.2a). The crystal structure of penton base (157) indicates that the 
monomer has two α-helices longer than 10 amino acids, corresponding to 10 long α-
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helices in the pentamer (Table 4.1, Figure 4.2b). These penton base α-helices are clearly 
resolved as density rods in the cryoEM reconstruction (Figure 4.2c, d, e).  
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Figure 4.2. Penton base α-helices resolved in the cryoEM reconstruction. (a) Surface 
representation of the penton base with a short portion of the protruding fiber indicated by 
a white bracket. Scale bar, 50 Å. (b) Penton base coordinates (PDB 1X9T) (157) with the 
α-helices of 10 or more residues shown as helical ribbons. The ribbon structure is 
rainbow colored with the N-terminus in blue and the C-terminus in red. The arrow 
indicates the position of the plane in (c). (c) Crop plane through penton base density 
showing that the two long α-helices per monomer (PDB 1X9T) are resolved as rods 
within the cryoEM density (mesh). (d) A perpendicular crop plane through penton base 
showing the agreement of the cryoEM density with the α-helices in the 1X9T penton base 
crystal structure (with a fiber peptide). (e) The same crop plane as in (d) but with the 
cryoEM density aligned with the 1X9P penton base crystal structure (without fiber). The 
arrowhead indicates the conformational switch region affected by fiber binding for one 
penton base monomer, which includes the α-helix (aa 482-491) shown in gold. Figure 
reprinted from (105) with permission from the American Society for Microbiology. 
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Table 4.1.  Long α-helices* in the penton base crystal structure (PDB ID 1X9T) (157) 
*Only α-helices of 10 or more residues are listed. 
 
Helix Residues Length (aa) 
h1 176 - 193 18 
h2 482 - 491 10 
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Two alternative crystal structures of the penton base have been solved: one in 
complex with an N-terminal fiber peptide (PDB 1X9T) and another without fiber (PDB 
1X9P) (157). Fiber binding drives a conformational switch in penton base residues 482-
505, which includes one of the two moderately long α-helices. The cryoEM density of 
penton base is clearly more consistent with the conformation of 1X9T (with fiber peptide) 
than that of 1X9P (without fiber) (Figure 4.2d,e), which is as expected since the Ad35F 
vector includes the Ad35 fiber. This result demonstrates the level of accuracy with which 
the 6 Å resolution cryoEM structure of Ad35F can be interpreted. 
Surface representations of hexon in the 6 Å resolution cryoEM reconstruction 
(Figure 4.3a) show a sharp protrusion for the HVR4 hypervariable region (103). The 
hexon crystal structure is missing six residues (aa 251-256) in the HVR4 region due to 
disorder (103). The cryoEM density suggests that these residues form an elongated loop 
protruding from the side of the hexon. The hexon PDB coordinate file was submitted to 
the CODA protein loop prediction web server (30) and several reasonable model loop 
structures were returned. The top ranked model generated by CODA fit best within the 
cryoEM density (Figure 4.3b). The crystal structure of hexon indicates that each 
monomer has six α-helices longer than 10 amino acids, corresponding to 18 long α-
helices in the trimer (Table 4.2, Figure 4.3c). The agreement between the cryoEM density 
rods and the α-helices in the crystal structure is shown for a hexon in position 4 of the 
asymmetric unit (Figure 4.3d). Two of these α-helices (h1 and h5) are at the bottom of 
the trimer. In the 9 Å resolution structure of Ad35F (104), these two helices were not 
fully resolved as cylinders but rather blended in with the surrounding non-helical density 
(Figure 4.3e). In addition all of these α-helices in the 6 Å resolution structure are resolved 
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as rods within each of the three other independent hexons in the asymmetric unit (data 
not shown). These results for hexon and penton base demonstrate that the resolution 
achieved for this cryoEM structure is sufficient to reliably identify α-helices within the 
adenovirus capsid. They also provide confidence for interpretation of the α-helices 
observed in the remaining cryoEM density for the additional capsid proteins.  
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Table 4.2.  Long α-helices* in the hexon crystal structure (PDB ID 1P30) (103) 
*Only α-helices of 10 or more residues are listed. 
 
Helix Residues Length (aa) 
h1 24 - 35 12 
h2 364 - 377 14 
h3 462 - 476 15 
h4 539 - 550 12 
h5 622 - 634 13 
h6 761 - 774 14 
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Secondary structure predictions for the additional capsid proteins 
In addition to hexon, penton base, and fiber, the adenovirus capsid also contains 
proteins IIIa, VI, VIII, and IX originally named for their mobility in polyacrylamide gels. 
Currently no atomic resolution structural information is available for these four proteins. 
Difference mapping, or subtraction of the pseudoatomic capsid of hexon and penton base 
from the cryoEM reconstruction, should reveal density for the additional capsid proteins 
if they are packaged with icosahedral symmetry. The adenovirus core, composed of the 
viral DNA as well as proteins V, VII, mu, and terminal protein, does not follow the 
icosahedral symmetry of the capsid and thus is not well reconstructed. The observation of 
α-helices within the cryoEM reconstruction opens up the possibility of assigning density 
to the additional capsid proteins based on their predicted α-helical content, as well as 
their known copy numbers and expected capsid locations. 
PsiPred secondary structure prediction (12) was performed for Ad5 proteins IIIa, 
VI, VIII, and IX. Only predicted α-helices of 10 or more residues are reported here, since 
these are the α-helices that should resolve at 6 Å resolution. Protein IIIa is likely to be 
highly α-helical, with 14 α-helices in the N-terminal two thirds of the sequence (aa 1-400) 
and 2 α-helices in the C-terminal third (aa 401-570) (Table 4.3). The first half of the 
mature form of protein VI is also likely to be α-helical, with two predicted α-helices of 20 
and 46 residues (Table 4.4). Submitting the full-length sequence of the precursor to 
protein VIII to the PsiPred server indicates one long α-helix of 24 residues in the 12.1 
kDa fragment (aa 1-111 of the precursor) and no long α-helices in the 7.6 kDa fragment 
(aa 158-227 of the precursor) (Table 4.5). For protein IX, the PsiPred server indicates no 
α-helices for the viral interaction domain (aa 1-39), two possible α-helices of 10 and 20 
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residues in the alanine-rich low complexity region (aa 60-90) in the middle of the 
sequence, and one long α-helix of 40 residues (aa 92-131) in the C-terminal half of the 
sequence (Table 4.6). The COILS, PAIRCOILS, and MULTICOILS web servers (4, 68, 
142) all indicate a strong propensity for coiled coil formation for the C-terminal α-helix 
of protein IX. In contrast, the coiled coil web servers indicate that coiled coils in proteins 
IIIa, VI, and VIII are unlikely. 
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Table 4.3.  Predicted α-helices* in Protein IIIa 
*Secondary structure prediction was performed using the PsiPred Server (12).  Only 
predicted α-helices 10 residues or longer are listed.  
 
Helix Residues Length (aa) 
h1 25 – 37 13 
h2 50 – 61 12 
h3 70 – 82 13 
h4 88 – 105 18 
h5 110 – 132 23 
h6 137 – 149 13 
h7 161 – 173 13 
h8 230 – 242 13 
h9 253 – 264 12 
h10 272 – 285 14 
h11 290 – 301 12 
h12 316 – 335 20 
h13 340 – 352 13 
h14 360 – 376 17 
h15 512 – 524 13 
h16 527 – 536 10 
 
 
Table 4.4. Predicted α-helices* in Protein VI 
*Secondary structure prediction was performed using the PsiPred Server (12).  Only 
predicted α-helices 10 residues or longer are listed.  
 
Helix Residues Length (aa) 
h1 39 – 58  20 
h2 62 – 107  46 
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Table 4.5. Predicted α-helices* in Protein VIII 
*Secondary structure prediction was performed using the PsiPred Server (12).  Only 
predicted α-helices 10 residues or longer are listed.  
 
Helix Residues Length (aa) 
h1 38 – 61 24 
 
 
Table 4.6. Predicted α-helices* in Protein IX 
*Secondary structure prediction was performed using the PsiPred Server (12).  Only 
predicted α-helices 10 residues or longer are listed.  
1Helix h3 is predicted to form a coiled coil. 
 
Helix Residues Length (aa) 
h1 57 – 76  20 
h2 79 – 88 10 
 h31 92 – 131 40 
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Reassignment of protein density on the capsid exterior 
In the 9 Å resolution difference map from Aim I, four trimeric regions of density 
per icosahedral facet and a large density lobe near each facet edge on the exterior of the 
capsid were observed (104). The trimeric density regions were confidently assigned to 
protein IX, since these sites had previously been shown by STEM to be occupied by 
protein IX (40). More precisely, volume analysis indicated that the trimeric regions 
corresponded to only the N-terminal virus interaction domains of protein IX. The density 
lobes observed at the facet edges were tentatively assigned as a domain of protein IIIa, in 
accord with an earlier cryoEM interpretation made at ~25 Å resolution (123). This 
assignment for protein IIIa was based mainly of the fact that the copy number of these 
lobes was in agreement with that of protein IIIa, with 60 copies per virion (61, 123), and 
also on an early observation that a least a portion of protein IIIa might be exposed on the 
outside of the capsid (34). 
The 6 Å resolution difference map generated by subtracting the pseudoatomic 
capsid from the cryoEM density also shows the four trimeric density regions in the 
middle of the facet and density lobes at the facet edges (Figure 4.4a). The trimeric density 
regions now display more structural detail. There is no indication for α-helices within 
these regions, which is consistent with the PsiPred secondary structure prediction for the 
N-terminal region of protein IX. Therefore, we interpret each trimeric region to be three 
copies of the N-terminal region of protein IX possibly up to residue 56, which is just 
before the first predicted α-helix.  
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Figure 4.4. Protein density on the exterior of the capsid. (a) A region of the cryoEM 
difference map (red) and pseudoatomic capsid (colored as in Figure 1c) roughly 
corresponding to one icosahedral facet. Four trimeric density regions and three helical 
bundles are observed. Density from missing residues in the hexon and penton base crystal 
structures has been removed except for the hexon HVR4 loops (pink) that connect to the 
helical bundles. (b) Enlarged views of the helical bundle shown in two views related by a 
180° rotation. The density is displayed with a lower isosurface in the 180° view to show 
the weak density corresponding to the fourth α-helix. The connected hexon HVR4 
density is in pink. Four α-helices, each 40 residues long (red), are shown fit within the 
density. The bracket indicates the 5 Å ladder-like spacing corresponding to the expected 
sidechain spacing for successive α-helical turns. (c) Enlarged view of one trimeric density 
region and a nearby helical bundle shown with a low isosurface to reveal that they appear 
to be almost connected. Two α-helices of 10 and 20 residues (green) are shown fit within 
the connecting density. (d) Diagram of our interpretation of the difference map density on 
the exterior of the capsid. The four trimeric density regions are assigned to four trimers of 
the N-terminal capsid interaction domain of protein IX (aa 1-56) (blue); the weak density 
connections are assigned to the low complexity midsection of protein IX (aa 57-91) 
(green); and the helical bundles are assigned to the C-terminal predicted α-helix of 
protein IX (aa 92-131) (red). The black dashed lines indicate presumably extended (non 
α-helical) connections between the central trimeric density region and the helical bundles. 
Note that one of the four helices in each bundle appears to come from a copy of protein 
IX in an adjacent facet. Scale bars, 50 Å. Figure reprinted from (105) with permission 
from the American Society for Microbiology. 
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One of the most dramatic differences between the 6 and 9 Å resolution cryoEM 
structures is that at higher resolution the density lobe at the facet edge is resolved into a 
four-helix bundle (Figure 4.4b). The density lobe appears to be four moderately long α-
helices twisting around each other as in a left-handed coiled coil. The cryoEM density 
clearly shows a 5 Å ladder-like spacing between the α-helices, which is consistent with 
the sidechain packing from sequential turns of an α-helix. The crystal structure of the 
tetrameric coiled coil domain of Sendai virus phosphoprotein (PDB 1EZJ) (126) served 
as good model for the observed coiled coil density. The 63 residue α-helix in the Sendai 
protein coiled coil was shortened to 40 residues, as predicted for the C-terminal protein 
IX α-helix, and manually fit within the cryoEM density (Figure 4.4b). The shortened 
four-helix bundle from the Sendai protein fit within the cryoEM density rods without any 
further modification. When displayed at a low isosurface value to include even weak 
density, the length of the adenovirus helical bundle appears to be ~40 residues long. 
Given that the secondary structural analysis indicates that of all the additional capsid 
proteins only protein IX has a strong propensity for coiled coil formation, the density at 
the facet edges is reassigned to the C-terminal region of protein IX. 
The density for one α-helix in the adenovirus coiled coil is stronger than that of 
the other three α-helices. In fact the fourth α-helix on the back side of the coiled coil is 
quite weak. These observations may be explained by the fact that only one of the 
α-helices, that with the strongest density, appears to interact with a neighboring hexon. A 
clear connection is seen between the strongest α-helix and the HVR4 loop of a hexon in 
position four of the asymmetric unit (Figure 4.4b). Based upon the model for the hexon 
HVR4 loop (Figure 4.3b), HVR4 residues K251 and N254 are the most likely sidechains 
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to interact with the coiled coil, since the other sidechains in the model point in the wrong 
direction. The weak density for three of the four α-helices suggests partial occupancy for 
these sites. Thus, the proposal presented in Chapter III that the C-terminal domain of 
protein IX may adopt two conformations, either binding on the capsid surface or 
extending away from the capsid (104), is still valid. The model can be elaborated to state 
that the C-terminal α-helices of protein IX may either cluster into the helical bundles at 
the facet edges, or possibly sit at other low occupancy sites on the capsid surface, or 
extend away from the capsid surface. Both low occupancy sites and extended 
conformations would be difficult to reconstruct by cryoEM single particle methods.  
As additional support for the new assignment for the C-terminal domain of 
protein IX, the trimeric density region closest to the helical bundle almost connects to the 
helical bundle at low isosurface values (Figure 4.4c). This density connection can be 
modeled as two α-helices of 10 and 20 residues, as predicted for the middle low-
complexity region of protein IX. Other partial connection arms are observed in the 
difference map, including an arm from the trimeric density along the facet edge that 
extends to the adjacent facet. The distance between various trimeric density regions and 
the helical bundles varies, so the low complexity region may adopt different 
conformations to span different distances. No connections are observed between the 
trimeric density region in the center of the facets and the helical bundles; however, if 
these connecting peptide regions are in an extended (non α-helical) conformation they 
would not be observed at this resolution. It appears that at least one of the four α-helices 
in the bundle may come from a neighboring facet. Our interpretation of the protein 
density in the difference map on the exterior of the capsid surface is shown schematically 
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in Figure 4.4d. If all four sites of all 60 helical bundles in the capsid are occupied, that 
would account for 240 (4 x 60) C-terminal domains of protein IX, in agreement with the 
copy number for protein IX in the adenovirus capsid. 
 
Internal capsid density assigned to protein VIII 
The 10 Å resolution cryoEM analysis of Fabry et al. led to an assignment for 
protein VIII to two elongated regions of density per asymmetric unit on the inner capsid 
surface (36). We concur with this assignment, as the 6 Å resolution difference map also 
shows two elongated and structurally similar density regions in the asymmetric unit on 
the inner capsid surface (Figure 4.5); however, the two independent copies of protein 
VIII are difficult to discern in the Ad35F 6 Å difference map without density 
segmentation. All of the density on the inner capsid surface in the 6 Å difference map is 
shown in Figure 4.5a for one icosahedral facet. The facet includes three asymmetric units, 
so six copies of protein VIII should be visible. Three copies of protein VIII are well 
resolved and surround the three copies of hexon in position 3 at the center of the facet. 
The other three copies of protein VIII are partially obscured by large clusters of α-helices 
below the penton bases at the corners of the facet. When these α-helical clusters are 
computationally removed, the additional copies of protein VIII become apparent. The 
two independent copies of the protein VIII in the asymmetric unit are shown in Figure 
4.5b. Each copy of protein VIII appears to interact with four hexons, although the hexons 
differ (2, 3, and 4; or 1, 2, and 4) depending on the protein VIII site. When the two 
independent volumes of protein VIII density are overlaid, they are nearly identical three-
dimensional structures (Figure 4.5c). Examination of the protein VIII density indicates 
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only one long α-helix of ~24 residues (Figure 4.5d), as predicted by PsiPred for the 12.1 
kDa fragment of protein VIII (Table 4.5).  
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Figure 4.5. Protein density on the interior of the capsid including protein VIII. (a) A 
region of the cryoEM difference map (red) and pseudoatomic capsid (colored as in Figure 
1c) roughly corresponding to one icosahedral facet viewed from inside of the capsid. 
Three separate triangular density regions previously assigned to protein VIII, as well as 
clusters of multiple α-helices below the penton base are observed. (b) Two independent 
copies of protein VIII (red) in the asymmetric unit. Density from other nearby proteins 
has been removed to reveal the similar three-dimensional structure of the two copies of 
protein VIII. (c) Overlap of the two independent copies of protein VIII density (red and 
cyan). (d) Fit of a 24-residue α-helix into the cryoEM density (mesh). Note that in this 
view other regions of protein VIII appear rod-shaped however interactive rotation of the 
density reveals that only one long α-helix is present as modeled. Scale bars, 50 Å. Figure 
reprinted from (105) with permission from the American Society for Microbiology. 
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Density assigned to protein VI within hexon cavities 
The hexon trimer has a large central cavity that faces the viral core and residue 
776, which has been implicated as a key residue in the hexon/protein VI interaction (141), 
is in a loop between two α-helices within the cavity (Figure 4.6). Thus, we carefully 
examined the difference map for any density within the hexon cavities. At a high 
isosurface value, only a few small, disconnected regions of density are observed in the 
hexon cavities and these disconnected regions appear as dots in Figure 4.5a. At a 
moderate isosurface value a disk-shaped region of density is observed at the top of each 
hexon cavity, as well as three rods of density near the bottom of the cavity (Figure 4.6). 
The disk-shaped density is surrounded by hydrophobic hexon residues at the top of the 
cavity including residues L463, L467, W468, and F471 from the three hexon monomers. 
The density rods come within 10 Å of the hexon loop with residue 776, which has been 
implicated in protein VI binding (141). At low isosurface the density disk at the top of the 
cavity connects to the three rods at the bottom of the cavity. Thus, all of the density 
within the hexon cavity is tentatively assigned to protein VI.  
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Figure 4.6. Density within the cavity of the hexon trimer tentatively assigned as protein 
VI. (a) Regions of the cryoEM difference map (red) near the hexon trimer in position 4 of 
the asymmetric unit. Only a thin plane of density through hexon is shown to reveal the 
central cavity. The hexon is oriented so that the exterior capsid surface is at the top and 
the interior surface is at the bottom. The hexon loop implicated in binding to protein VI is 
shown in green (aa 770-787). The density at the top of the hexon cavity is indicated by an 
arrowhead and two of the three density rods near the base of the cavity are marked with 
arrows. (b) A perpendicular thin plane of density showing the close proximity of hexon 
loop (aa 770-787) (green) to the rod-like density indicated by arrows. (c) Regions of the 
cryoEM difference map (red) near the hexon trimer in position 2 of the asymmetric unit. 
The plane is thicker than (a) and rotated in order to visualize the connection between the 
density rod (arrow) and the density folded over the base of the hexon (bracket). Figure 
reprinted from (105) and modified with permission from the American Society for 
Microbiology. 
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In contrast to the ~25 Å resolution structure of adenovirus that placed protein VI 
solely at the vertex region (123), the 6 Å structure of adenovirus reveals protein VI 
density within the cavities of all four hexons in the asymmetric unit. The density within 
the cavities also connects to density that folds over onto the bottom of the hexons, 
indicating that perhaps not all of the mature form of protein VI fits within the hexon 
cavity (Figure 4.6c). Similar density lining the hexon cavities was also observed at 9 Å 
resolution (104), but it is now resolving into subunits positioned on symmetry related 
sites on the inner surface of the hexon trimers. Consideration of stoichiometry indicates 
720 possible binding sites for protein VI, or three potential binding sites in each of the 
240 hexon trimers. However, mass spectrometry indicates only ~369 copies of protein VI 
per virion (61). Therefore, it seems likely that there is partial occupancy of all 720 
possible binding sites for protein VI. This may explain the weak cryoEM density for 
protein VI in the Ad35F reconstruction.  
 
A new assignment for protein IIIa on the inner capsid surface 
 A second major difference between the 6 and 9 Å resolution cryoEM structures is 
that the density below the penton base on the inner capsid surface is now resolved as 
large clusters of α-helices (Figure 4.7a). At 9 Å resolution this density was speculated to 
correspond to proteins IIIa, VI, or VIII or to the adenovirus protease (104). Now that α-
helices are resolved at 6 Å resolution, a more informed assignment can be made. Protein 
IIIa is unique among the adenovirus capsid proteins in that secondary structure prediction 
indicates that it is a highly α-helical protein with an α-helical content of nearly 50%. 
PsiPred predicts at least 14 α-helices in the N-terminal two thirds and 2 α-helices in the 
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C-terminal one third of the sequence (Table 4.3). Each of the five helical clusters below 
the penton base contains at least 13 α-helices, in reasonable agreement with the predicted 
number for the N-terminal two thirds of protein IIIa. The copy number of this helical 
cluster is also consistent with mass spectrometry data for protein IIIa, with 60 copies of 
protein IIIa per virion, or one copy per asymmetric unit (61).  
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Figure 4.7. Internal capsid density assigned to protein IIIa. (a) Density in the difference 
map below the penton base includes protein VIII and clusters of multiple α-helices. One 
fifth of the density from the difference map is shown in red and the remainder in gray. A 
region of the pseudoatomic capsid is shown colored as in Figure 1c. (b) Enlarged view of 
one fifth of the density from the difference map. This includes one cluster of α-helices 
assigned to the N-terminal region (aa 1-400) of one protein IIIa monomer (red), together 
with one copy of protein VIII (gray), and unidentified density, possibly protein VI, at the 
base of a hexon (orange). (c) Fit of 13 α-helices, ranging in length from 12 to 23 residues, 
into the α-helical density assigned to protein IIIa (mesh). Scale bars, 50 Å. Figure 
reprinted from (105) with permission from the American Society for Microbiology. 
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Now that α-helices are resolved in the cryoEM density, none of the other 
alternative protein candidates for the density below the penton base seems reasonable. 
The crystal structure of the adenovirus protease (73) clearly does not fit within this α-
helical density. Protein VIII is now accounted for in the difference map. Even if the 
current protein VIII assignment is incorrect, two copies of protein VIII per asymmetric 
unit would contribute only two long α-helices per asymmetric unit, which is not enough 
to account for the observed helical cluster of 13 helices per asymmetric unit. Protein VI is 
a possible, but highly unlikely, candidate for the helical cluster. PsiPred predicts two long 
α-helices in protein VI (Table 4.4), and given that there are ~369 copies of protein VI per 
virion this would imply ~6 copies per asymmetric unit that could in principle account for 
12 α-helices per asymmetric unit. However, the helical cluster appears much more like a 
folded protein domain than a multimer with 2 helices contributed from each of 6 copies 
of protein VI. Also assigning the helical cluster to a multimer of protein VI is not very 
compatible with the ts147 mutant data indicating that protein VI binds in the hexon cavity 
(141).  
 Therefore, the most likely assignment for the helical cluster below the penton 
base is the N-terminal domain of protein IIIa, which has 14 predicted α-helices (Table 
4.3). Before attempting to fit α-helices within the helical density, we segmented one 
helical cluster from its neighboring five-fold related clusters and from the nearby copy of 
protein VIII (Figure 4.7b). In addition, we segmented away a small region of density on 
the bottom of the hexon. Similar density is found on the bottom of all copies of hexon in 
the capsid, and thus it is likely to be protein VI or perhaps a core component that 
associates with the capsid. 
 75
 After segmentation, 13 canonical α-helices ranging in length from 12 to 23 
residues were fit within the helical cluster (Figure 4.7c). This accounts for all but one of 
the predicted α-helices in the N-terminal two thirds of protein IIIa. Clearly, at this 
resolution there is not a unique solution for placement of the α-helices within the density 
since in general the length of an α-helix can only be predicted to within a few residues 
and also since there are multiple predicted α-helices for protein IIIa with the same or 
similar length. Nevertheless the fit of α-helices presented in Figure 4.7c supports the 
assignment of the N-terminal region of protein IIIa to the helical cluster of density below 
the penton base. 
Consideration of the 5-fold symmetry of the vertex region implies that 5 copies of 
protein IIIa bind in five symmetrically arranged areas on penton base as shown in Figure 
4.7a. These 5 copies of protein IIIa nearly cover the entire accessible inner surface area of 
penton base. Based upon the pseudoatomic capsid, the penton base residues that are 
likely to interact with the helical cluster assigned to protein IIIa can be predicted (Table 
4.7). The protein IIIa/penton base interface involves ~38 penton base residues, including 
residue 52, which is the first ordered residue in the crystal structure (Figure 4.8). It seems 
likely that the N-terminal tail of penton base (aa 1-51) is also involved in the interaction. 
The PsiPred server predicts just one α-helix with a high level of confidence for the N-
terminal tail of the penton base, and it is only 7 residues long. At most one short helical 
density rod in the helical cluster assigned to protein IIIa might correspond to the N-
terminal tail of penton base. This new assignment for protein IIIa below the penton base 
on the inner capsid surface is in accord with the biochemical findings that protein IIIa is 
 76
one of the more labile capsid components and is released shortly after the penton base in 
thermally- and low pH-induced disassembly assays (47, 96, 140). 
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Table 4.7. Penton base and hexon interactions with the protein IIIa density. 
1Some of these residues are also within 10 Å of protein VI 
 
Penton Base Hexon 
Monomer 1 Monomer 2 Chain A Chain B 
52 – 66 116 – 117 5 – 241 633 – 641 
111 – 119 567 – 569 42 – 611 669 – 673 
532 – 534  89 – 91 877 – 878 
564 – 569  620 – 6391 880 – 8981
  928 – 933 925 – 931 
   938 – 945 
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Figure 4.8. Protein interactions between protein IIIa and penton base. (a) A ribbon 
representation of penton base (157) (yellow) viewed along the 5-fold axis, and surface 
representations of portions of a neighboring hexon (green) and the density assigned to 
protein IIIa (gray). The residues in penton base that are within 10 Å of protein IIIa are in 
blue. (b) Same as (a) but with the protein IIIa density removed. The first residue (aa 52) 
resolved in the crystal structure of penton base is shown as a red sphere. Scale bar, 50 Å. 
Figure reprinted from (105) with permission from the American Society for 
Microbiology. 
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Protein IIIa forms an extensive interaction surface with a peripentonal (position 1) 
hexon (Figure 4.9). This interaction involves over 90 residues from two monomers within 
the trimer and may also include the first four N-terminal residues from one monomer that 
are missing from the crystal structure (Table 4.7). Although the interaction of the helical 
cluster is predominantly with one peripentonal hexon, portions of the helical cluster also 
interact with an adjacent peripentonal hexon and with a nearby hexon in position 4 
(Figure 4.7a, b). Some of the hexon residues within 10 Å of protein IIIa are also within 
10 Å of density likely to be protein VI (Table 4.7). 
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Figure 4.9. Protein IIIa interactions with hexon. (a) A ribbon representation of a 
peripentonal (position 1) hexon (103) (green) viewed along the trimeric 3-fold axis, and 
surface representations of a portion of penton base (yellow), the internal protein IIIa 
density (gray), and the density likely to be protein VI (orange). The residues in hexon that 
are within 10 Å of protein IIIa density are in magenta, and those with 10 Å of both 
proteins VI and protein IIIa are in cyan. (b) Same as (a) but with the protein IIIa and 
density likely to be protein VI removed to reveal the full interaction sites on hexon. The 
first residue (aa 5) resolved in the crystal structure of hexon monomer chain A is shown 
as a red sphere. 
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Discussion 
The collection and averaging of more cryoEM particle images as well as the use 
of improved image processing techniques enabled us to determine a 6 Å resolution 
structure for Ad35F. This resolution is significant in that α-helices can now be resolved in 
the capsid. Docking of the hexon and penton base crystal structures allowed us to confirm 
that all α-helices of 10 or more residues are resolved as rods within the cryoEM density. 
One improvement that had a significant effect on the resolution was to process particle 
images with a smaller pixel size of 1.5 Å on the molecular scale. This increased the size 
of the reconstructed volume to 7503, which in turn significantly increased the memory 
requirement to ~20 GB, but we found this to be essential in order to reach 6 Å resolution. 
A second improvement that led to higher resolution was correction for the astigmatism in 
the cryo-micrographs, which was accomplished with the Frealign software package (48). 
Two significant new features were revealed in the 6 Å resolution adenovirus 
structure that were not apparent at 9 Å. First, a density lobe at the facet edge on the 
exterior of the capsid that had long been assumed to be a domain of protein IIIa is now 
resolved into a four helix bundle. Structure predictions indicate that only protein IX has a 
strong propensity for coiled coil formation, thus we have revised our assignment for this 
exterior density region to a bundle of C-terminal α-helices from protein IX. The early 
assignment of this density region to protein IIIa is understandable when one considers 
that the density of four 40-residue α-helices is quite significant (~18 kDa). Before this 
density region was resolved into α-helices there was no easy way to determine if this 
represented 18 kDa from a single capsid protein or an assembly of domains from multiple 
copies of a capsid protein. The recent cryoEM results of Fabry et al. (36) on Ad5 and an 
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adenovirus protein IX deletion mutant actually support this new assignment although it 
was not clear at the time. They found that when protein IX was deleted, regardless of 
whether or not the sample was subjected to a single or multiple freeze/thaw cycles, the 
density previously proposed as protein IIIa at the facet edges was also missing. Our new 
assignment of the density at the facet edges to a bundle of protein IX C-terminal α-helices 
is consistent with their published findings.  
The second new feature observed at 6 Å resolution is that the large regions of 
density internal to the penton base are actually clusters of 13 or more long α-helices. 
Consideration of secondary structure prediction results for all of the capsid protein 
without atomic resolution structures makes it highly probable that these clusters are N-
terminal domains of protein IIIa, which are predicted to have 14 long α-helices. The 
helical cluster forms extensive interaction surfaces with a peripentonal hexon and with 
the penton base. Interestingly, a biopanning study using a phage-display peptide library 
found that a peptide from protein IIIa (aa 157-162 for Ad5) binds to penton base (54). 
The biopanning result is in agreement with our new assignment for protein IIIa. Also, 
argon plasma etching experiments point toward a position for protein IIIa between the 
adenovirus capsid and core (82). Our findings are also in accord with the well established 
copy number for protein IIIa of 60 copies within the adenovirus virion, or one copy per 
asymmetric unit (61).  
The new assignments for proteins IX and IIIa, which are based on the observation 
of α-helical density and secondary structure prediction, can be tested biochemically. We 
have proposed that the C-terminal α-helix of protein IX forms a four-helix bundle and 
that one α-helix in the bundle interacts with residues in the hexon HVR4 loop. We have 
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also proposed that the N-terminal two thirds of protein IIIa is likely to fold into a defined 
domain that interacts with the inner surface of penton base and hexon, and also with an 
unidentified region of protein VI. Protein IIIa appears to form multiple associations with 
each of the other proteins in the vertex region of the icosahedral capsid, suggesting a 
crucial role for protein IIIa as a linchpin for virus assembly and vertex disassembly.  
Careful kinetics studies of adenovirus cell entry have indicated that adenovirus 
particles exist in a metastable state being relatively stable outside of the cell but 
weakened by the dissociation of structural proteins during the cell entry process so that it 
can efficiently release its DNA when it reaches the nucleus (47). Wiethoff et al. reported 
that protein IIIa disassociates from the adenovirus capsid at about the same time as 
penton base and one quarter of the hexons, which are presumably the peripentonal hexons 
next to penton base (140). Given these previous findings and our new structural 
information, we propose a more complete model of adenovirus disassembly. When 
penton base dissociates from the capsid, protein IIIa would also likely be released 
bringing with it the peripentonal hexons, and multiple copies of protein VI. Protein VI is 
thought to exist in the virion as a dimer or trimer (18, 35). If multiple copies of protein VI 
are connected either by direct homotypic association or via interactions with other 
adenovirus proteins in the core, this would explain the observation by Wiethoff et al. that 
~80% of protein VI dissociates at the same time as protein IIIa. Protein VI is the 
adenovirus component that participates in disruption of the endosomal membrane and 
thus its release from the adenovirus virion is essential for cell entry. We propose that the 
multiple protein-protein interactions made by protein IIIa in the vertex region facilitate 
the release of the membrane lytic protein VI. 
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CHAPTER V 
 
NON-ENVELOPED VIRAL MEMBRANE PENETRATION 
 
Cellular entry processes have been widely studied for many viruses. 
Understanding these early steps in the viral life cycle is fundamental for the development 
of vaccines and anti-viral drugs. To fully infect host cells, viruses need access to the 
cytoplasm or nucleus; therefore, they must penetrate at least one cellular membrane. A 
common strategy employed by enveloped viruses to access the cellular space is fusion of 
the viral and a cellular membrane such as the plasma or endosomal membrane. Upon the 
appropriate trigger such as receptor binding for HIV or low pH for influenza virus, 
glycoproteins situated in the viral membrane undergo a conformational change and 
mediate the fusion. On the contrary, non-enveloped viruses lack lipid bilayers, so they 
cannot breach cellular membranes by a viral-host membrane fusion event. Instead they 
must employ fundamentally different strategies to breach the cellular barrier. These 
processes are less well understood than the analogous events for enveloped viruses. 
As viruses assemble, they achieve a metastable state primed for cell entry. They 
must remain stable as they encounter numerous different environments when traveling 
from host to host. When the virus reaches the appropriate cellular membrane to cross, it 
must transform itself into a penetration competent state. As with enveloped viruses, non-
enveloped viruses need a signal to indicate that the appropriate membrane is near. This 
signal triggers a conformational change or a cascade of changes that exposes the 
 85
penetration protein(s). The membrane is modified in some way that allows the passage of 
the viral particle or genetic material into the cytoplasm.  
Pre- and post-fusion structures of enveloped virus glycoproteins have been well 
characterized. They are classified according to the presence of an N-terminal fusion 
peptide in a mainly α-helical glycoprotein (Class I) or a hydrophobic loop within a β-
sheet (Class II) (59). Classification of non-enveloped penetration proteins is more 
challenging because their structure and conformational changes during activation are less 
understood. Although the structures of many penetration proteins and details of cell entry 
mechanisms are largely unknown, non-enveloped viruses can be discussed in terms of the 
types of proteins with known or predicted penetrating capability including fusion-like 
capsid proteins, myristoylated capsid proteins, capsid proteins with amphipathic helices, 
and enzymatic capsid proteins. A common theme among non-enveloped viruses is 
sequestration of the penetration protein until the appropriate time in the viral life cycle. 
The portion of virus that needs to cross the membrane may influence how penetration 
proteins interact with host membranes. 
 
Fusion–like penetration proteins
Some penetration proteins show remarkable similarities to the fusion 
glycoproteins of enveloped viruses. An example is VP4 of rotavirus. Rotavirus is a 
double-stranded RNA virus and the most prevalent etiological agent of childhood 
gastroenteritis, which kills approximately 440,000 infants annually (89). A rotavirus 
vaccine (RotaTeq, Merck & Co., Inc.) is now available against 4 serotypes, but the 
mechanism of immune protection is not known. The study of the rotavirus cell entry 
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mechanism including membrane penetration could yield insights into vaccine-based 
immunity and possibly new vaccines. Rotavirus has a capsid with 3 concentric layers and 
resembles a spoked-wheel with long VP4 protrusions rooted near the VP6 intermediate 
capsid layer. There are 120 copies of VP4 in the outer capsid layer. The importance of 
VP4 is indicated by its participation in cell attachment, penetration, hemagglutination, 
neutralization, virulence, and protease-enhanced infectivity, hence the interest in 
understanding its structure (33). 
Rotavirus replicates in the enterocytes of the small intestine, an environment 
abundant in proteases. Trypsin primes rotavirus for infectivity by cleaving VP4 into 
VP5* and VP8* resulting in the formation of rigid spikes (113, 148). The spikes are 
bilobed indicating a dimer, but they have pseudohexagonal symmetry at the surface of the 
outer capsid indicating the presence of a third VP4 molecule in the vicinity. The crystal 
structure of VP5* missing the anchoring foot (VP5CT) reveals that VP5* can also exist 
as a trimer (Figure 5.1b) (31). The trimer is stabilized by a triple helix coiled-coil. A β-
annulus is formed by the coalescence of strand K from each subunit, and it connects the 
helix of each subunit to a folded-back globular domain comprised by an 8-stranded 
antiparallel β sandwich. At the tip of the β sandwich is a hydrophobic apex presumed to 
interact with the membrane. Interestingly, the antigen domain of VP5*, which lacks the 
helix and strand K of VP5CT, can pack as a trimer or dimer with essentially the same 
fold indicated by the low RMSD of 0.85 Å (149). The dimer has both N- and C-termini at 
the same end of the structure (Figure 5.1a) while VP5CT has its termini at opposing ends 
indicating a fold back relative to the foot domain, the C-terminus (Figure 5.1b).   
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Figure 5.1 Structures of the VP5* protein of rotavirus. (a) Crystal structure of the VP5* 
antigen domain dimer (PDB ID: 2B4H) (149) with the N- and C-termini indicated by 
blue and red spheres, respectively. The putative membrane interaction loop is in green. 
The membrane interaction loop is shielded by the companion protein, VP8* (black circle). 
The remaining stalk (red box) and foot of VP5* (black circle) not crystallized would 
extend from the C-terminus to the rotavirus capsid. (a,b) The two outer concentric capsid 
layers of VP7 and VP6 are indicated by black lines. (b) Crystal structure of the VP5CT 
trimer (PDB ID: 1SLQ) (31) contains the stalk region of VP5* (aa 480-525) (red). The 
membrane interaction loop points towards the VP7 capsid layer. The foot domain of 
VP5* (black circle) would connect to the C-terminus of the stalk. Figure rendered with 
UCSF Chimera (92). 
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The dimer is proposed as a “primed” state for cell entry, similar to the dimeric 
metastable state of class II viral fusion proteins upon budding from cellular membranes 
(59, 149). A trimer of the VP5* antigen domain was able to form even without the 
stabilizing coiled coil and β-annulus of VP5CT. A trilobed spike is also observed in the 
cryoEM structure of rotavirus treated with high pH (91). Thus, the trimer is proposed to 
be biologically relevant even though the trigger that could induce a dimer to trimer 
rearrangement with a fold-back of the antigen domain is unknown. This proposed 
oligomeric rearrangement is strikingly similar to the membrane fusion mechanism used 
by Semliki Forest virus (alphavirus), dengue virus (flavivirus) and tick-borne encephalitis 
virus (flavivirus) with class II fusion loops (59). In pre-fusion structures the fusion loop 
lies at the tip of a β-sheet shielded by a companion protein analogous to VP8* in 
rotavirus (Figure 5.2a-c) (63, 77, 79, 97, 100, 154). Post-fusion crystal structures of class 
II fusion proteins indicate that they undergo a dimer to trimer reorganization and a fold-
back with a conserved fold upon exposure to low pH (Figure 5.2d-e) which is presumed 
to bring the two membranes into close proximity (11, 42, 78). 
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Figure 5.2 Pre- and post-fusion structures of dengue virus E protein. (a) Neutral pH (pre-
fusion) crystal structure of the soluble ectodomain of the E membrane fusion protein of 
dengue virus (PDB ID: 1OAN) (77). Residues 395 – 495 containing the putative 
transmembrane region were not crystallized. Blue, yellow, red, and green represent 
domains I, II, and III and the fusion loop as defined in (77). The N- and C-termini are 
indicated by blue and red spheres, respectively. (a, d, e) The viral lipid bilayer is 
represented by 2 black lines. (b) View rotated 90° with respect to (a) showing the dimeric 
oligomeric state of E. (c) A monomer of E in the same orientation as (b). (d) Low pH 
(postfusion) crystal structure (PDB ID: 1OK8) (78) of the E as a trimer. (e) A monomer 
of E in the postfusion conformation in the same orientation as (d). Figure rendered with 
UCSF Chimera (92). 
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Myristoylation: not merely a coincidence
 Non-enveloped viruses in many virus families share the post-translational 
modification of myristoylation at the N-terminal residue of a capsid protein. 
Myristoylation involves the substitution of myrisitc acid, a saturated tetradecanoic fatty 
acid, for the first residue of the polypeptide chain. The myristoyl moiety is believed to 
insert into the cellular membrane to mediate penetration. Although direct evidence of 
membrane insertion is lacking in many cases, there is a relationship between 
myristoylated capsid proteins and cell entry or virus viability. VP4 of poliovirus is one of 
the best-documented cases. 
Poliovirus is a member of the picornavirus family and was one of the most 
devastating human pathogens of the 20th century. Hence, its structure and mechanisms of 
cell entry and membrane penetration have been widely studied. The icosahedral capsid 
contains the typical picornavirus proteins, 60 copies of VP1, VP2, and VP3. Their N-
termini create a network with 60 copies of myristoylated VP4 on the inner surface of the 
capsid near the 5-fold rotational axis (53). In the course of infection the native 160S 
particle binds to the poliovirus receptor (Pvr), a cell adhesion-like molecule with 3 Ig-like 
domains (74). This binding induces an irreversible conformational change to the 135S or 
A-particle. Upon receptor binding, Fricks & Hogle showed that the A particle has 
reduced affinity for the receptor; the N-terminus of VP1 is externalized; and VP4 is 
released (39). The 135S particle can then be eluted from membrane fractions, but VP4 
remains associated with membranes (29). The externalized N-terminal domain of VP1 
has a role in binding to membranes since its proteolytic removal abrogates binding to 
liposomes (39). A putative amphipathic helix was identified in the N-terminal 20 residues 
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of VP1, and it was postulated to insert in the membrane to form an ion channel to allow 
the single-stranded RNA genome passage into the cytoplasm (39).  
The initial studies showing a conformational change in VP1 and release of VP4 in 
response to binding Pvr did not clarify the role of myristoylated VP4 in membrane 
penetration (39). In the crystal structure of poliovirus, 5 VP4 molecules are situated near 
the 5-fold rotational symmetry axis, and the myristoyl moiety of one VP4 forms a 
hydrogen bond with threonine 28 of a nearby VP4 (53). To investigate a potential role of 
myristoylation in membrane penetration, Moscufo et al. constructed VP4 point mutants 
and discovered that a T28G mutation rendered the virus noninfectious (80). This 
mutation did not affect the 160S to 135S transition meaning that VP4 could be released 
from the virion; however, the mutation did cause the particles to be defective in 
delivering the RNA genome to the cytoplasm (29). Viable mutants with Thr28 
substitutions to serine or valine were able to form ion channels in lipid bilayers as wild 
type 135S particles, but the T28G mutant was defective in ion channel formation. This 
evidence suggests that VP4 has an active role in cell entry in that VP4 affects the ability 
of the virus to form ion channels. Thus, VP4 may directly contribute to the architecture of 
the ion channel.     
Polyomavirus is another example in which myristoylation appears to play a role in 
viral cell entry (69). Polyomavirus is a dsDNA tumor virus, and its capsid is composed 
72 pentamers of VP1 (120) with VP3 or myristoylated VP2 associated with the 
icosahedral 5-fold axis on the inner surface of the virion (20). Following transport to the 
endoplasmic reticulum (ER), ER protein 29, a possible member of the stress response 
machinery of the ER, induces a conformational change in VP1 exposing the C-terminus 
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as observed by mass spectrometry (69). The resulting particle is hydrophobic and can 
bind to membranes. Virus-like particles containing only VP1 could not associate with 
liposomes, which implicates another capsid protein in membrane association. The protein 
is most likely VP2 since mutants devoid of myristoylation have dramatically reduced 
infectivity, delayed growth, and a defect early in cell entry at or before uncoating, 
perhaps in membrane association (107). Crystallographic studies suggest a mechanism 
for VP2 exposure. The VP1 pentamer co-expressed with a fragment of VP2 reveals the 
C-terminus of VP2 tightly associated with VP1 and the N-terminal portion unresolved 
and flexible (20). A VP1 rearrangement could allow the extrusion of VP2 giving the 
flexible N-terminus an avenue to interact with a cellular membrane.  
 
Amphipathic helices in membrane penetration 
Human Ads, double-stranded DNA viruses, and poliovirus, a single-stranded 
RNA virus, both utilize predicted amphipathic helices in membrane penetration. In 
poliovirus, the predicted amphipathic helix is in the N-terminus of VP1. The N-terminus 
is important in the early steps of cell entry. If the N-terminus is removed 135S particles 
cannot attach to liposomes (39), and N-terminal mutations cause delayed RNA release 
(60). VP4 has been shown to associate with membranes, and VP4 mutations directly 
impact pore formation and function (29). Whether VP1 directly contributes to pore 
architecture or anchors the 135S particle to the membrane independently or via VP4, it 
clearly works in unison with VP4. Even though poliovirus presents a case where a 
putative amphipathic helix acts in concert with a second penetration protein, mounting 
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evidence suggests that known or predicted amphipathic helices can be the primary 
mediators of membrane penetration as is the case for Ad. 
The adenovirus protein VI has recently been shown to be critical for membrane 
penetration (140). Although its atomic structure is not known, protein VI is predicted to 
have an amphipathic helix in the N-terminal portion of the protein. The role of protein VI 
in membrane penetration was surprising since the penton base had been suggested to 
mediate membrane penetration (110, 111). The penton base interacts with αv integrins to 
initiate internalization (139). Inhibitory effects of anti-penton base antiserum in the Seth 
et al. study may have interfered with internalization rather than membrane penetration 
(110).   Membrane penetration has been associated with partial capsid disassembly in the 
endosome (47). Interestingly, a temperature-sensitive mutant of Ad2, ts1, cannot escape 
endosomes and is recycled back to the plasma membrane (46). The P137L mutation in 
the ts1 cysteine protease hinders its encapsidation and activation at the non-permissive 
temperature (93). As a consequence ts1 does not produce mature copies of protein VI and 
VIII, both internal capsid proteins (137). In an attempt to understand the relationship 
between disassembly and membrane penetration, Wiethoff et al. discovered that ts1 is 
defective in disassembly, and protein VI remains associated with the capsid compared to 
~80% release from wt adenovirus virions (140). When protein VI is immunodepleted in a 
liposome disruption assay, membrane disruption is dramatically reduced. On the other 
hand, immunodepletion of the penton base has no significant effect on liposome 
disruption. Recombinant protein VI is also able to mediate lipid disruption and 
fluorophore release, and the first 54 residues containing the predicted amphipathic helix 
are indispensable for the lytic activity.  
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Nemerow and colleagues are carrying out in vivo experiments to further 
substantiate the participation of the putative helix of protein VI in membrane penetration 
by creating single or double point mutations in the putative amphipathic helix (personal 
communication, unpublished data). Two of the adenovirus mutant constructs cannot be 
rescued and therefore may have lethal phenotypes while several other mutants have 
modestly reduced infectivity as measured by plaque assays. In general, protein VI 
mutants are properly incorporated into virions, and there are no obvious defects in 
disassembly. Further experiments are planned to determine whether mutations alter 
protein VI/lipid interactions.  
An animal virus, flock house virus, has a known α-helix in the C-terminus of its 
capsid protein with multiple helices converging at the 5-fold axis (21). A 44-residue 
cleavage fragment (γ1) is autocatalytically derived encompassing the C-terminal α-helix. 
It was postulated that γ1 forms a pore in membranes that mediates genome translocation 
to the cytoplasm. A 21-residue synthetic γ1 peptide is capable of releasing liposome-
bound fluorescent dyes and conducting ions across a membrane (7). Collectively, these 
results demonstrate that amphipathic helices comprise a third class of penetration proteins.  
 
Enzymatic penetration proteins 
A new class of penetration proteins has recently been identified with one known 
constituent. Parvovirus is a small dsDNA virus composed of 60 copies of only 2 capsid 
proteins, VP1 and VP2. An active phospholipase A2 (PLA2) is encoded in the N-terminal 
domain of VP1 which is capable of converting phospholipids into fatty acids and other 
lipophilic substances (152). The N-terminus of VP1 can be exposed in vitro by limited 
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heating (27). Antibodies against the N-terminus of VP1 can block infection when injected 
into the cytoplasm during parvovirus cell entry suggesting that the VP1 N-terminus is 
externalized during cell entry (136). A mutation in the PLA2 domain abrogates lipase 
activity and renders the virus noninfectious (37). Farr et al. were able to increase the 
infectivity of the mutant by supplying an endosomal rupture agent, polyethyleneimine, or 
by coinfecting with adenovirus as long as protein VI, the penetration protein of Ad, is 
released (37). Thus, parvovirus uses a previously unrecognized enzymatic mechanism to 
pierce a cellular membrane, which is a notable exception to the hydrophobic nature of 
other classes of penetration proteins.   
 
Penetration proteins are shielded until needed 
The particular site of penetration must be coupled to the requirements of the virus 
life cycle. Exposing the penetration protein too early could be toxic to the host cell before 
replication begins. If spatial coupling is lost, the penetration protein of a dsDNA virus 
like polyomavirus could be exposed at the cell surface rather than later in the 
endoplasmic reticulum, which would probably interfere with genome delivery to the 
nucleus for replication. An emerging theme in membrane penetration by non-enveloped 
viruses is the sequestration of the penetration protein until the preferred cellular 
membrane is near.  
The membrane penetrating ability of reovirus is thought to originate from 
myristoylated μ1 (85), a major outer capsid protein present in 600 copies. Even though 
μ1 is the major protein on the outside of the capsid (Figure 5.3a-c), Reovirus has devised 
a clever strategy to shield the myristoyl moiety until the release trigger is received. In the 
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atomic resolution structure of μ1 complexed with its protector protein, σ3, a hydrophobic 
pocket was found on the side of the μ1 trimer (1 pocket/monomer) which contained the 
crystallization detergent (64). Liemann et al. proposed that the myristoyl group occupies 
this pocket in the intact virion. The first eight residues were disordered, so additional 
information is needed to address this hypothesis. In a recent cryoEM analysis of reovirus 
at 7.0 Å resolution, Zhang et al. observed a tube of density extending from Thr10 of the 
docked crystal structure to the hydrophobic binding pocket observed by Liemann et al. 
consistent with the idea of the N-terminus reaching to this pocket and shielding the 
hydrophobic myristoyl group (Figure 5.3d-e) (153).   
 97
  
 
 
Figure 5.3 Reovirus cryoEM density at 7Å resolution. (a) CryoEM structure of the 
reovirus virion viewed along the 2-fold rotational axis. (a,b,c) The scale bar represents 
200 Å. (b and c) Pseudoatomic models of the virion (b) and ISVP (c) generated by 
docking the μ1/σ3 heterohexamer (PDB ID: 1JMU) (64) and λ2 (PDB ID: 1EJ6) (95) (b) 
or λ2 and the μ1 hexamer only (c) into the cryoEM density. λ2 pentamers are in magenta, 
σ3 in blue, and μ1 trimers in cyan, pink, orange, and brown. The asymmetric unit is 
outlined by a white triangle and P2 and P3 channels (b) and capsid proteins (c) are 
labeled. (d) Close-up view of cryoEM density (mesh) and 2 docked μ1 trimers. A 
myristoyl group (red) is modeled in the hydrophobic pocket identified in (64). Extra 
cryoEM density (green mesh) has been assigned to aa 2 – 9 and a preliminary backbone 
trace for these residues is shown in blue. Thr10 is marked by a blue sphere. (e) 
Demagnified view in the same orientation as (d) showing a modeled myristoyl group in 
each trimer. Also a tentative trace for residues 72 – 96 is shown (magenta). Scale bar, 25 
Å. Figure reprinted from (153) and modified with permission from Elsevier. 
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As with adenovirus, reovirus undergoes major structural changes during 
endocytosis. The outer capsid protein, σ3, is lost after cleavage by lysosomal acidic 
proteases, which generates infectious subvirion particles (ISVPs). ISVPs, not virions or 
cores, have membrane penetrating activity (129). The formation of ISVPs is followed by 
dissociation of the fiber protein (σ1), and a conformational change in μ1 renders ISVPs 
hydrophobic. The hydrophobic form of ISVP has been proposed as an additional cell 
entry intermediate called ISVP* (16, 17, 86).  During cell entry, μ1 is autocatalytically 
cleaved between Asn42 and Pro43, which produces 4 kDa (μ1N) and 72 kDa (μ1C) 
fragments (37, 84). Cleavage of Asn/Pro43 appears to occur after the conformational 
change in μ1 because a μ1N/μ1C cleavage mutant, μ1N42A, contained the hydrophobic 
form of μ1 (86). Although the ISVP → ISVP* transition has not been characterized 
structurally, it could involve extracting the myristoyl group from the binding pocket and 
setting up for the Asn42/Pro43 cleavage. The μ1N fragment is normally released 
following cleavage. The μ1N42A mutant retains the μ1N fragment and is not able to 
permeabilize membranes in vitro or in vivo indicating that the generation of μ1N and its 
release are important in cell entry (84, 86).  
 The 6 Å resolution cryoEM reconstruction of Ad5 pseudotyped with the short 
fiber from Ad35 (Ad35F) suggests that the adenovirus penetration protein, protein VI, 
may be shielded in a fashion similar to that of reovirus μ1. Density in the cavity of the 
hexon has been assigned to protein VI based upon proximity to hexon residue 776, which 
has been implicated in protein VI binding (141). There are three symmetry-related 
density rods that are within 10 Å of the three copies of hexon residue 776 (Figure 4.6). 
Some of the density rods extend and fold over the base of the hexon (Figures 4.6c and 
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5.4a). Both the density rod within the hexon cavity and a portion of the region folded 
over the base of the hexon are long enough to accommodate ~3 helical turns (Figure 
5.4b,c). These could be the predicted α-helices of the N-terminal region of protein VI. 
Both predicted α-helices overlap the N-terminal hexon binding domain (hbd1) (Figure 
5.4d). Hbd1 includes residues 48 – 74 which is about 3 kDa in molecular mass (72). At a 
moderate isosurface level, the volume of the protein VI rod and the protein VI density 
folded over the base of hexon corresponds to ~2.5 kDa in molecular mass, which is 
consistent with the size of hbd1. Therefore, the density in the cavity of the hexon is 
tentatively assigned to the N-terminus of protein VI including the membrane lytic region. 
In this model, the nuclear localization signal, NLS1 (aa 131 – 135) (Figure 5.4), does not 
fall in the region of protein VI bound to the hexon cavity. Since one of the functions of 
protein VI in the adenovirus life cycle is shuttling hexon to the nucleus for viral assembly 
(141), NLS1 and NLS2 must be accessible while protein VI is associated with hexon. 
This model suggests that the N-terminal region of protein VI is shielded in the hexon 
cavity until its membrane lytic activity is needed in the life cycle.  
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Figure 5.4 Density within the cavity of the hexon trimer assigned as the N-terminal 
domain of protein VI. (a) Region of Fig 4.6c magnified to show only the protein VI 
density rod and density folded over the base of the hexon (red). The hexon coordinates 
are shown in gray ribbons and loop implicated in protein VI binding (aa 770 – 787) is 
shown in green. (b) Protein VI density (gray mesh) fitted with 9- and 14- residue helices 
(magenta).  (c) View as in (b) with a 90 degree rotation. (d) Schematic bar diagram of 
protein VI. Hexon binding domains 1 and 2 are shown in gray, and nuclear localization 
and export signals are marked by blue and black diagonal lines, respectively. Predicted 
helices are shown by brackets, with the amphipathic helix marked by an asterisk. (See 
Table 4.4). Protease cleavage sites at residues 33 and 239 are marked by arrows.  
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Penetration protein interactions with membranes
Although crystal structures are available for poliovirus (53), μ1 of reovirus (64), 
and fragments of myristoylated VP2 from polyomavirus (20) among others, high 
resolution structures for many penetration proteins have not been determined. Solving 
structures of penetration proteins solubilized under penetrating conditions or in the 
context of an intact membrane presents a daunting challenge. Thus, the precise events in 
membrane penetration by non-enveloped viral proteins have not been adequately 
addressed. With the limited knowledge to date it is surmised that penetration proteins 
form discrete pores of limited size in the case of rhinovirus (10), large membrane 
disturbances in the case of adenovirus (10), or perhaps induce chaperone-assisted 
transport in the case of polyomavirus (69). Since non-enveloped viruses can be single- or 
double-stranded DNA or RNA viruses, what needs to cross the cellular membrane and 
the membrane to be traversed differs. How the penetration protein interacts with the 
cellular membrane is most likely dictated by the constraints of the virus life cycle.  
Poliovirus has a single, plus-stranded RNA genome meaning that the genome is 
ready for translation in the cytoplasm and must produce the virally encoded RNA-
synthesizing machinery to make minus strands for replication. Even though the exact site 
of penetration has not been elucidated, only the RNA needs to cross the membrane for a 
viable infection to ensue. If only the RNA needs passage, then a large membrane 
disturbance would not be necessary. Rhinovirus is also a member of the picornavirus 
family. In endosome leakage experiments rhinovirus allowed the release of only small 
dextran molecules consistent with the idea of a small pore that would facilitate transport 
of RNA, which is approximately 10 Å in diameter (10). Experiments confirm that 
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poliovirus cell entry intermediates form pores in planar lipid bilayers of about 20 Å in 
diameter (128) and that VP4 is most likely involved in pore formation (29).  
Reovirus has markedly different needs for replication. Reovirus relies on the 
transcriptionally active core to produce mRNA transcripts from the dsRNA genome 
followed by mRNA liberation from the 5-fold vertex. It is not clear when the transition 
from ISVP to transcriptionally active core particle is made, but at least the core needs 
access to the cytoplasm where transcription begins. The breach in the ~100 nm 
endosomal vesicle must be at least ~70 nm in diameter to allow cores to pass 
unobstructed. One study reported the formation of multisized channels in planar lipid 
bilayers; however, the size distribution of such channels was not clear including the size 
that could be formed in vivo (129). Recently, it was discovered that μ1N must be released 
to permeabilize membranes (86), and if 600 copies are released simultaneously the 
membrane could be carpeted and ruptured for release of the core particle. Although 
channel formation has been reported in vitro, a large membrane disturbance should not be 
ruled out as the mechanism by which reovirus exits the late endosome. 
Since adenovirus is a double-stranded DNA virus, its genome must replicate in 
the nucleus. Adenovirus particles have been detected in the cytoplasm and even docked at 
the nuclear pore complex (45). The ~93 nm capsid must also exit endosomal vesicles of 
~100 nm in diameter. Thus, a large membrane disturbance seems more likely than 
channel formation. Data supporting this notion comes from experiments analyzing the 
release of different size dextran molecules from endocytic vacuoles (10). Following the 
dissociation of the penton base and protein IIIa in the acidified endosome, nearly 300 
copies of protein VI are deployed (140). The concentration of protein VI in the endosome 
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is approximately 2 mg/ml (G.Nemerow, personal communication). It seems plausible that 
this massive release of protein VI could carpet and rupture the endosomal membrane 
allowing the partially disassembled virion access to the cytoplasm and microtubules for 
transport to the nucleus.  
 
Conclusions 
Non-enveloped viruses have devised clever strategies to penetrate host cell 
membranes to gain access to the cytoplasm. Both structural and functional analyses have 
indicated that membrane penetration by non-enveloped viruses can involve a fusion-like 
mechanism as is the case for rotavirus, myristoylated capsid proteins for viruses like 
polyomavirus and reovirus, or a capsid protein with an amphipathic helix like in Ad. The 
discovery of enzymatic membrane lysis by an NEV has generated a new class of 
penetration proteins that rely on characteristics significantly different than penetration 
proteins with hydrophobic domains in other classes. A common feature of all classes is 
the protection of the lytic protein or domain until membrane penetration is needed. The 
interactions between non-enveloped viral proteins and membranes appear to be related to 
the cytoplasmic passage of viral genetic material, a transcription complex, or a viral 
capsid.  
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CHAPTER VI 
 
SUMMARY AND CONCLUSIONS 
 
Adenovirus has been at the heart of gene therapy development as evidenced by 
the numerous clinical trials in progress using adenovirus-based vectors as therapeutic 
agents (52). Adenovirus-based gene therapy is promising, but there are obstacles to 
overcome in the process of bringing therapies to the bedside. Most prominent is the 
activation of the host immune response when delivering first generation vectors 
intravenously. Major efforts are underway to retarget adenovirus vectors away from 
CAR-expressing tissues and towards other desired targets. Ad35, a subgroup B virus, 
shows great promise as a vector due to its ability to infect non-CAR expressing cells. In 
preliminary mouse in vivo studies the Ad35F vector (117), which is composed of the Ad5 
capsid pseudotyped with the Ad35 fiber, primarily infects tumor tissue and evades 
immune system activation typically seen with Ad5 vectors (83). The absence of a high 
resolution structure of adenovirus has hampered further vector development, and this has 
been a motivating factor in the work presented in this dissertation. This chapter 
summarizes the significance of solving subnanometer resolution structures of adenovirus, 
the impact of visualizing α-helices on protein assignments, implications of this work for 
viral assembly and capsid disassembly, and possible future adenovirus structural studies. 
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Significance of determining subnanometer resolution structures of Ad 
 The major challenge of imaging biological complexes with an electron 
microscope is that proteins suffer radiation damage induced by the electron beam. To 
compensate for the low signal-to-noise ratio in two-dimensional particle images, large 
data sets on the order of 104 – 105 particle images are averaged. The literature indicates 
that α-helices can be resolved when the structure reaches ~10 Å resolution (56), so our 
first goal was to reach this resolution level for the adenovirus reconstruction. There are a 
growing number of cryoEM structures in the subnanometer resolution range (56), but 
only one subnanometer resolution structure has been determined for a complex as large 
or larger than adenovirus: herpesvirus at 8.5 Å resolution (156). Herpesvirus has an 
icosahedral capsid of 1250 Å in diameter surrounded by a proteinaceous tegument layer 
and a glycoprotein envelope. At 8.5 Å resolution, it was observed that the distribution α-
helices in the VP5 and VP23 capsid proteins did not match any in known viral structures, 
indicating that VP5 and VP23 may have unique folds.  
It has been predicted that 100,000 views of the asymmetric unit are necessary to 
reach 10 Å resolution and approximately 1 million to reach atomic (3 Å) resolution (43). 
The number of particles can be reduced if the complex of interest has symmetry. For 
example, adenovirus is an icosahedral virus with 60-fold symmetry, and thus the 
predicted number of images necessary to reach 10 Å resolution is 1,667 (100,000/60 = 
1,667) and to reach atomic resolution is 16,667 (1,000,000/60 = 16,667). We were able to 
achieve 9 Å resolution for Ad35F reconstruction in Aim I with only 960 particle images, 
significantly less than the predicted number. In Aim II we were able to refine the Ad35F 
structure to 6 Å resolution with just over 2,600 particle images, or 156,000 views of the 
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asymmetric unit (2,600 x 60 = 156,000). For comparison the cryoEM structure of GroEL 
at 6 Å resolution (67) was produced with 39,000 particle images. Considering the 14-fold 
symmetry of GroEL this corresponds to 546,000 views of the asymmetric unit (39,000 x 
14 = 546,000), which is over three times the number of views of the asymmetric unit than 
we used in the 6 Å resolution structure of Ad35F. These results imply that processing 
with the highest quality data may make the daunting challenge of achieving atomic 
resolution by cryoEM imaging more manageable.  
  
Impact of visualizing α-helices on protein assignments 
We have shown that cryoEM can provide sufficient resolution of a viral structure 
to resolve α-helices. In the Aim I structure of Ad35F at 9 Å resolution, we were able to 
visualize a long ~40 residue α-helix, which we assigned to the C-terminus of protein IX. 
The shorter α-helices of the other capsid proteins without atomic resolution structures 
were not observed, so in Aim II we refined the Ad35F reconstruction to 6 Å resolution.  
In the Aim II structure we were able to resolve α-helices of 10 residues or longer. After 
fitting the crystal structures of hexon and penton base into the cryoEM reconstruction, we 
confirmed that each α-helix of at least 10 residues (3 or more turns) in the crystal 
structures was resolved as a rod in the cryoEM density map.   
Achieving the milestone of resolving α-helices allowed us to re-evaluate the 
density assignments made in the first adenovirus difference map at 25 Å resolution (123). 
This was the first demonstration that electron density maps are accurate enough to allow 
crystal structures to be docked into their corresponding locations in the EM envelope. In 
1993 only the hexon crystal structure was available for this study, and it was docked into 
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240 positions in the adenovirus capsid and subtracted to reveal density for the other 
capsid proteins. The difficulty in interpreting a 25 Å resolution difference map of a 
complex viral capsid is discerning whether density regions represent individual proteins 
or multimers of domains from multiple proteins. For this reason the 60 tetrameric coiled 
coils of protein IX were incorrectly assigned to 60 copies of protein IIIa. It is now clear 
that all of the density in addition to hexon, penton base, and fiber on the outer surface of 
the virion is protein IX rather than a combination of protein IX and protein IIIa. This 
implies that all the other capsid proteins are internal. Visualizing α-helices also enabled 
us to make another major density reassignment for inner capsid density. The density 
formerly assigned to multimers of protein VI at 25 Å resolution is now resolved into a 
helical cluster closely associated with vertex proteins on the inner capsid surface. 
Comparison of the number and length of observed α-helices with secondary structure 
predictions for proteins IIIa, VI, and VIII made clear that the cluster is protein IIIa. The 
proximity of protein IIIa to protein VI density nestled in the adjacent hexon cavity has 
important implications for capsid disassembly.  
 
Implications for viral assembly 
Protein IX has been known as the capsid ‘cement’ since protein IX mutant virions 
are more heat labile and do not form characteristic groups of nine (GON) hexons when 
dissociated. Protein IX and hexon are a few of earliest components incorporated into 
progeny virions together with the penton base and scaffolding proteins, which are 
subsequently released and are not found in mature virions (44). The 9 Å resolution 
structure of Ad35F revealed that the four trimeric regions of density observed in each 
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icosahedral facet interacting with the GON hexons are most likely trimers of only the N-
terminal domain of protein IX. Our findings suggest that the strict requirement for the 
conserved N-terminal domain of protein IX for incorporation into virions during 
assembly (98) is a result of the N-terminus of protein IX interacting with the GON 
hexons.  
The refinement of the protein IIIa position helps clarify the known role of protein 
IIIa in viral assembly. Temperature-sensitive mutants with defects in DNA encapsidation 
have mutations in protein IIIa indicating that protein IIIa has a role in packaging the viral 
genome (25).  With the prior assignment of protein IIIa on the outer capsid surface and a 
small portion on the inner capsid surface, it was difficult to envision how protein IIIa 
could facilitate DNA packaging (123). Biochemical studies indicate that protein IIIa 
crosslinks to protein VII (34), a core protein known to interact with the viral DNA. The 
assignment of the tetrameric coiled coil on the outer capsid surface to protein IX and the 
reassignment of protein IIIa to the cluster of helices associated with vertex proteins on the 
inner capsid surface placed protein IIIa entirely in the interior of the particle. The C-
terminal one-third of protein IIIa, core proteins, and the viral DNA were not observed in 
the reconstruction suggesting that protein IIIa interacts with protein VII via its C-terminal 
region. This interaction would effectively link the capsid with the core proteins and viral 
DNA, which could facilitate packaging of the genome during viral assembly.  
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Implications for capsid disassembly during cell entry 
The reassignment of protein IIIa density has also allowed us to form new 
hypotheses on capsid disassembly. Protein VI participates in disruption of the endosomal 
membrane, and its release from the adenovirus virion is essential for cell entry. Protein 
VI is sequestered in the interior of the virus probably because it is toxic to cells, and it 
would be advantageous to keep it shielded until its lytic activity is needed during cell 
entry. The cryoEM structure suggests that the membrane lytic predicted amphipathic 
helix is shielded in the hexon cavity. In adenovirus, it is known that low pH triggers the 
liberation of the penton base, about a quarter of the hexons, and the majority of protein 
IIIa and VI. Prior to this work it was not evident how a significant percentage of protein 
VI could be efficiently released for endosomal membrane penetration. The newly 
assigned protein IIIa density is closely associated with the penton base, 25% of protein 
VI, and 25% of hexons.  The cryoEM structure suggests that the nearly simultaneous 
release of these proteins during cell entry may be a result of the extensive protein/protein 
interfaces observed between protein IIIa and both hexon and penton base. Biochemical 
data suggest that protein VI forms trimers or dimers (18). If protein VI forms a network 
within the virion, then rapid vertex dissociation facilitated by protein IIIa would provide 
an efficient avenue for the release of a significant percentage of protein VI from the 
virion. In addition to a role for protein IIIa in DNA encapsidation during virion assembly, 
we propose that protein IIIa serves as the linchpin for vertex dissociation in cell 
endosomes to facilitate the release of the membrane lytic protein VI. 
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Future Adenovirus Structural Studies
The Ad35F cryoEM structures at 6 and 9 Å resolution have allowed refinements 
in the assignment of capsid density; however, a higher resolution structure could further 
enhance our understanding of the capsid. At 6 Å resolution α-helices were visualized in 
the adenovirus capsid, but the resolution was not great enough to identify large side 
chains. Thus, a unique fold could not be proposed for protein IIIa. Achieving 4.5 or 3 Å 
resolution cryoEM single particle reconstruction would be a landmark achievement not 
only for adenovirus, but also for the cryoEM community. In a cryoEM helical 
reconstruction at 4 Å resolution of flagellin, which forms the bacterial flagellar filament, 
the backbone was traced for 100 terminal residues that were missing from the F41 
fragment (150). In the core of the filament, the path of the α-helical backbone and some 
large side chains were visible. By refining the 6 Å resolution Ad35F structure to  4.5 Å 
resolution it may be possible to resolve large, bulky side chains and begin to trace the 
fold for capsid proteins IIIa, VI, VIII, and IX. Once large sidechains are resolved in 
hexon and penton base, then bulky residues could be visualized in α-helices thereby 
giving directionality to the peptide backbone. Visualization of large sidechains in the 
protein IIIa density would be particularly useful in de novo fold modeling studies 
underway in collaboration with Jens Meiler’s laboratory. At 6 Å resolution, modeling 
techniques could not differentiate between 2000 possible models for the structure of 
protein IIIa. Sidechain information from a 4.5 Å resolution structure could help reduce 
the candidate models in order to converge upon the unique fold for protein IIIa. Likewise, 
visualization of bulky sidechains in the protein VI density, could help confirm that the N-
terminal membrane lytic region of protein VI is shielded within the hexon cavity. 
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The resolution of the Aim II structure of Ad35F leveled off at 6.9 Å using a 
conservative estimate (0.5 Fourier Shell Correlation criterion), and suggests how the 
structure could be refined to higher resolution. Approximately 65% of the images 
reconstructed originated from dataset 1, which had a final pixel size of 2.4 Å. By the 
Nyquist Theorem it would be theoretically possible to achieve 4.8 Å resolution (two 
times the pixel size of 2.4 Å), but a resolution of three times the pixel size is more likely, 
7.2 Å resolution. The remaining 35% of the particle images had a pixel size of 1.5 Å 
(dataset 3), and by including them in the reconstruction the resulting resolution was better 
than three times the pixel size of dataset 1. This implies that collecting and processing 
more images like dataset 3 would make refinement to 4.5 Å resolution possible with the 
Frealign image processing software package. Furthermore, processing images similar to 
dataset 3 and binned by three to a pixel size of 1.1 Å could make atomic (~ 3 Å) 
resolution achievable for adenovirus by cryoEM. 
 
Concluding remarks 
 These structural studies using cryoEM single particle reconstruction techniques 
have greatly enhanced our knowledge of the adenovirus capsid architecture. In Aim I we 
determined a 9 Å resolution structure of adenovirus and this enabled us to visualize a 40-
residue long α-helix in the capsid.  In Aim II we determined a 6 Å resolution structure of 
adenovirus and this enabled us to resolve all α-helices of 10 or more residues in the 
cryoEM density.  Resolving α-helices has been pivotal in understanding where proteins 
are located in the capsid. The Aim II structure also suggested that protein IIIa may have 
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an additional role in the adenovirus life cycle. The new knowledge of the locations of 
capsid proteins will likely pave the way for future vector retargeting approaches. 
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